abstraet
picornavirus
among
best
understood
anim
virus
molecular
term
number
import
human
anim
pathogen
member
picornavirida
famili
genom
organ
differ
step
picornaviru
growth
numer
compound
report
inhibitor
picornaviru
function
review
picornaviru
particl
sever
agent
intereact
solv
atom
resolut
lead
computerassist
drug
design
picornaviru
inhibitor
use
aid
better
understand
picornaviru
biolog
addit
promis
therapeut
agent
clinic
efficaci
agent
bind
picornaviru
particl
alreadi
demonstr
abbrevi
ppp
na
bfa
brefeldin
bafilomycin
ai
dsrna
doublestrand
rna
emc
encephalomyocard
fmdv
footandmouth
diseas
viru
hbb
cthydroxybenzyl
benzimidazol
hiv
human
immunodefici
viru
ammonium
icami
intercellular
adhes
moleculel
inositol
triphosph
quereetin
ire
intern
ribosom
entri
site
l
protein
leader
protein
rf
replic
form
ri
replic
intermedi
rlp
ribosom
land
pad
sfv
semliki
forest
viru
tofa
tetradecyloxi
acid
vpg
viral
protein
bound
genom
vsv
vesicular
stomat
viru
introduct
picornavirida
famili
object
interest
mani
research
group
year
result
member
viru
famili
among
best
understood
anim
virus
molecular
term
number
excel
review
publish
cover
differ
aspect
picornavirolog
putnak
phillip
koch
koch
carrasco
castrillo
rossmann
johnson
sonenberg
palmenberg
stanway
racaniello
lawson
semler
richard
ehrenfeld
minor
sarnow
et
al
minor
kirkegaard
agol
harber
wimmer
picornavirus
structur
simpl
appear
spheric
particl
nm
diamet
possess
icosahedr
symmetri
genom
molecul
singlestrand
rna
posit
polar
famili
first
divid
four
genera
enteroviru
cardioviru
rhinoviru
aphtoviru
recent
addit
genu
hepatoviru
recogn
basi
genom
sequenc
organ
fig
member
group
great
import
medicin
veterinari
scienc
pathogen
human
anim
henc
econom
ecolog
interest
exampl
includ
polioviru
caus
agent
poliomyel
coxsacki
viru
factor
respons
caus
heart
diseas
echo
virus
caus
mening
human
three
belong
enteroviru
genu
main
caus
agent
common
cold
rhinovirus
genu
rhinoviru
hepat
viru
caus
hepat
previous
classifi
enteroviru
genu
includ
hepatoviru
genu
stanway
harber
wimmer
final
infect
agent
one
threaten
afflict
cattl
footandmouth
diseas
member
aphtoviru
genu
although
effect
vaccin
develop
virus
polioviru
hepat
viru
develop
vaccin
member
group
rhinovirus
yet
achiev
murdin
et
al
minor
minor
thu
import
develop
antivir
agent
combat
diseas
apart
use
antivir
agent
respect
compound
play
pivot
role
molecular
virolog
inde
antivir
agent
use
elucid
numer
viral
process
identifi
exact
target
agent
molecular
level
addit
antivir
agent
provid
clean
accur
tool
aid
dissect
complic
molecular
step
viral
genom
replic
henc
antivir
agent
molecular
virolog
inhibitor
molecular
biolog
picornaviru
inhibitor
repres
good
exampl
compound
use
provid
better
understand
biolog
picornavirus
also
furnish
promis
agent
assay
clinic
trial
common
cold
instanc
larg
number
compound
avail
select
blockad
differ
step
picornaviru
replic
cycl
make
agent
invalu
tool
picornavirologist
difficult
organ
comprehens
review
cover
although
tri
includ
mani
exampl
possibl
approach
use
agent
employ
inevit
coverag
incomplet
apologis
advanc
whose
work
includ
despit
merit
shall
review
structur
picornaviru
particl
differ
step
replic
cycl
topic
cover
begin
section
deal
specif
picornaviru
inhibitor
shall
briefli
outlin
instead
structur
genom
take
polioviru
repres
member
viral
famili
polioviru
first
picornaviru
fact
first
anim
viru
rna
genom
sequenc
kitamura
et
al
racaniello
baltimor
soon
achiev
infecti
edna
obtain
thu
open
new
possibl
genet
manipul
import
human
pathogen
racaniello
baltimor
omata
et
al
sarnow
et
al
kirkegaard
rna
genom
stretch
nucleotid
almost
encod
protein
sarnow
et
al
harber
wimmer
fig
aug
initi
protein
synthesi
locat
posit
preced
sever
aug
depend
viru
serotyp
recogn
translat
initi
complex
initi
aug
follow
codon
code
polyprotein
cleav
virusencod
proteas
lawson
semler
palmenberg
two
termin
codon
follow
nucleotid
preced
poli
stretch
averag
length
nucleotid
yogo
wimmer
genet
determin
encod
genom
infect
viral
rna
contain
longer
poli
tail
nucleotid
presum
ad
replic
spector
baltimor
b
spector
et
ai
length
genom
disposit
differ
viral
protein
vari
somewhat
among
differ
picornaviru
genera
depict
fig
perhap
remark
variat
presenc
addit
l
leader
protein
strebel
beck
footandmouth
diseas
viru
fmdv
encephalomyocard
emc
viru
code
three
copi
protein
vpg
virtual
lack
protein
amino
acid
fmdv
stanway
presenc
ofa
poli
c
tract
variabl
length
leader
region
cardioviru
clark
et
al
stanway
nucleotid
locat
polioviru
genom
number
function
yet
fulli
elucid
sarnow
et
al
kirkegaard
among
follow
may
list
region
necessari
replic
rna
genom
least
part
nucleotid
requir
initi
synthesi
polyprotein
region
involv
genom
packag
virion
particl
polioviru
neurovirul
mutant
map
region
addit
leader
sequenc
may
involv
process
requir
viru
replic
thu
one
viral
proteas
protein
precursor
interact
region
perhap
regul
genom
replic
andino
et
al
b
furthermor
polioviruscoxsacki
hybrid
gener
contain
nucleotid
coxsacki
viru
replac
nucleotid
polioviru
semler
et
al
hybrid
ts
mutant
genom
replic
one
salient
featur
yend
picornaviru
mrna
contain
cap
structur
typic
eukaryot
mrna
instead
viral
rna
termin
pupu
within
virion
particl
replic
viral
genom
end
coval
bound
case
polioviru
virusencod
peptid
amino
acid
lee
et
al
peptid
viral
protein
also
known
vpg
viral
protein
bound
genom
nomoto
et
ai
b
sinc
picornaviru
mrna
cap
structur
initi
protein
synthesi
genom
unusu
initi
translat
eukaryot
mrna
commenc
recognit
cap
structur
initi
complex
process
involv
capbind
protein
kozak
recognit
follow
attach
scan
yend
initi
complex
aug
found
correct
context
start
translat
kozak
caven
ray
picornaviru
mrna
translat
initi
complex
bind
instead
intern
region
locat
nucleotid
pelleti
sonenberg
picornavirus
initi
complex
scan
remain
yend
initi
aug
found
might
even
jump
transloc
directli
aug
pyrimid
stretch
uuuccuuuu
region
conserv
picornavirus
beck
et
al
nucleotid
uuucc
combin
posit
seventh
aug
locat
nucleotid
upstream
initi
aug
involv
intern
initi
translat
nucleotid
locat
termin
codon
poli
tail
play
role
replic
viral
rna
sarnow
et
al
inde
function
region
synthesi
negativestrand
copi
rna
indic
presenc
pseudoknot
region
iizuka
et
al
jacobson
et
al
implic
structur
replic
viral
rna
also
consid
pleij
poli
tail
play
function
stabil
mrna
infect
polioviru
rna
without
tail
reduc
sarnow
addit
poli
particip
replic
viral
rna
richard
ehrenfeld
ribosom
start
translat
initi
aug
travel
codon
polioviru
genom
gener
polyprotein
harber
wimmer
polyprotein
found
infect
cell
cleav
still
polysom
lawson
semler
first
cleavag
accomplish
viral
proteas
releas
precursor
pi
capsid
protein
see
diagram
depict
fig
toyoda
et
al
viral
proteas
protein
synthes
cleav
section
hanecak
et
al
therefor
viral
proteas
activ
precursor
abl
cleav
ci
inde
matur
proteas
gener
infect
also
activ
tran
palmenberg
lawson
semler
detail
proteolyt
event
specif
proteas
reader
refer
sever
excel
review
palmenberg
palmenberg
lawson
semler
hellen
wimmer
apart
cleavag
accomplish
viral
proteas
final
cleavag
event
occur
assembl
process
protein
gener
plu
palmenberg
palmenberg
cleavag
catalyz
conjunct
viral
rna
palmenberg
hellen
wimmer
case
polioviru
matur
protein
plu
differ
array
precursor
produc
thu
make
analysi
protein
synthesi
picornavirusinfect
cell
complex
jacobson
baltimor
summer
maizel
figur
show
appear
polypeptid
twodimension
polyacrylamid
gel
nomenclatur
picornaviru
precursor
matur
protein
ration
known
nomenclatur
rueckert
wimmer
indic
section
picornavirus
encod
protein
preced
capsid
protein
known
l
protein
synthesi
l
protein
follow
four
capsid
protein
region
seven
polypeptid
involv
veget
function
region
three
region
genom
pi
distinguish
accord
two
proteolyt
cleavag
take
place
polyprotein
polysom
level
matur
protein
encod
region
number
follow
letter
b
c
thu
eleven
matur
protein
known
capsid
protein
also
known
origin
name
given
name
viral
protein
possibl
identifi
locat
genom
precursor
protein
known
combin
name
instanc
precursor
although
protein
even
found
infect
cell
gener
genet
engin
picornavirus
possess
small
virion
particl
whose
structur
atom
resolut
solv
hogl
et
al
rossmann
et
al
luo
et
al
acharya
et
al
kim
et
al
rossmann
johnson
krishnaswami
rossmann
yeat
et
al
grant
et
al
smyth
et
al
virion
spheric
shape
exhibit
icosahedr
symmetri
rossmann
johnson
compos
copi
structur
protein
plu
copi
genom
rna
contain
one
copi
genomebound
viral
protein
vpg
genom
protein
coval
attach
viral
rna
ester
bond
tyrosin
present
vpg
last
nucleotid
viral
rna
lee
et
al
virion
compos
ident
asymmetr
unit
form
copi
structur
protein
although
three
virion
surfac
locat
intern
hogl
et
al
rossmann
johnson
determin
structur
picornaviru
protein
reveal
virion
protein
differ
amino
acid
sequenc
similar
tertiari
structur
hogl
et
al
rossmann
et
al
acharya
et
al
rossmann
johnson
grant
et
al
tertiari
structur
also
share
singl
protein
capsid
mani
plant
rna
virus
suggest
kind
basic
structur
brick
exist
within
differ
virion
particl
rossmann
johnson
protein
fold
give
rise
basic
brick
depict
fig
compos
two
fourstrand
flsheet
quit
similar
differ
virus
hogl
et
al
rossmann
et
al
acharya
et
al
rossmann
johnson
minimum
number
amino
acid
requir
form
flbarrel
rossmann
johnson
may
insert
variabl
size
strand
cage
traquetoid
contain
common
eightstrand
antiparallel
barrel
motif
amino
termini
intertwin
link
thu
form
network
interior
capsid
five
amino
termini
form
fivestrand
helicalcylind
virion
interior
hogl
et
al
rossmann
et
al
acharya
et
al
rossmann
johnson
myristoyl
amino
terminu
chow
et
al
paul
et
al
urzainqui
carrasco
myristoyl
moieti
lie
insid
virion
coat
near
flcylind
rossmann
johnson
surfac
protom
depress
depth
absent
aphtovirion
hogl
et
al
rossmann
et
al
acharya
et
al
rossmann
johnson
depress
canyon
implic
interact
virion
particl
receptor
neutral
antibodi
enter
depress
rossmann
johnson
rossmann
olson
et
al
fig
viral
infect
commenc
recognit
attach
virion
particl
specif
molecul
locat
surfac
cell
socal
receptor
dale
dimmock
lentz
chemic
natur
receptor
molecul
vari
depend
speci
viru
infect
cell
mani
identifi
receptor
protein
particularli
glycoprotein
dale
dimmock
lentz
principl
singl
viru
speci
use
differ
receptor
molecul
singl
cell
type
differ
kind
cell
addit
differ
viru
speci
use
receptor
land
cell
becom
infect
dale
dimmock
lentz
presenc
receptor
cell
surfac
determin
mani
instanc
viral
tropism
ie
suscept
given
set
cell
organ
infect
particular
viru
dale
dimmock
lentz
addit
interact
virus
cell
surfac
receptor
one
target
viral
infect
might
block
lentz
case
picornavirus
receptor
molecul
polioviru
rhinoviru
identifi
gene
encod
glycoprotein
clone
protein
product
express
character
greve
et
al
mendelsohn
et
al
staunton
et
al
tomassini
et
al
receptor
belong
superimmunoglobulin
famili
protein
see
review
racaniello
harber
wimmer
polioviru
receptor
compos
three
immunoglobulinlik
domain
locat
surfac
cell
hydrophob
transmembran
domain
anchor
receptor
membran
cytoplasm
ctermin
region
mendelsohn
et
al
koik
et
al
fig
intercellular
adhes
cellular
receptor
rhinovirus
staunton
et
al
glycoprotein
bind
lymphocyt
functionassoci
antigen
interact
involv
immunolog
respons
staunton
et
al
receptor
molecul
compos
five
immunoglobulinlik
extracellular
domain
transmembran
domain
hydrophob
natur
short
ctermin
cytoplasm
domain
staunton
et
al
larg
amount
truncat
lack
hydrophob
cytoplasm
domain
obtain
marlin
et
al
truncat
form
solubl
interact
rhinoviru
particl
marlin
et
al
hooverlitti
greve
olson
et
al
structur
truncat
icami
complex
rhinoviru
particl
determin
use
cryoelectron
microscopi
indic
receptor
bind
canyon
olson
et
al
b
avail
cdna
clone
code
polioviru
receptor
made
possibl
analysi
structur
relev
gene
transcript
deriv
differ
cell
line
koik
et
al
koik
et
al
morrison
racaniello
polioviru
receptor
gene
contain
eight
exon
transcript
produc
number
splice
variant
mrna
koik
et
al
duplic
polioviru
gene
found
monkey
two
gene
encod
differ
loci
genom
koik
et
al
mous
l
cell
infect
polioviru
transfect
gene
encod
polioviru
receptor
mendelsohn
et
al
transgen
mice
gener
carri
polioviru
receptor
gene
ren
et
al
koik
et
ai
ren
racaniello
mice
suscept
polioviru
could
constitut
good
anim
model
test
efficaci
polioviru
vaccin
antivir
activ
polioviru
inhibitor
anim
bind
virion
particl
receptor
induc
conform
chang
virion
protein
could
trigger
interact
protein
membran
frick
hogl
hooverlitti
greve
subsequ
transloc
activ
virion
protein
put
motion
thu
induc
passag
virion
lipid
bilay
carrasco
virion
protein
therefor
endow
transloc
activ
similar
display
domain
polypeptid
toxin
howev
transloc
capac
yet
assign
picornaviru
protein
model
indic
receptor
molecul
regard
play
activ
role
viru
entri
frick
hogl
carrasco
et
al
hooverlitti
greve
receptor
bind
particl
cell
surfac
bind
induc
virion
conform
chang
requir
uncoat
virion
particl
moor
et
al
hooverlitti
greve
see
section
process
requir
allow
penetr
membran
entri
cytoplasm
frick
hogl
hooverlitti
greve
agreement
find
bind
opson
polioviru
mous
l
cell
lead
infect
mason
et
al
indic
simpl
attach
polioviru
cell
surfac
suffic
initi
infect
thu
viral
receptor
cell
play
role
beyond
attach
mason
et
al
although
lower
ph
endosom
contribut
conform
chang
occur
virion
process
necessari
eas
polioviru
carrasco
see
section
even
envelop
virus
recent
investig
bind
envelop
virion
receptor
also
induc
conform
chang
viral
glycoprotein
respons
membran
fusion
moor
et
al
meyer
et
al
principl
low
ph
would
requir
induc
conform
chang
lead
membran
fusion
case
envelop
virus
would
provid
protonmot
forc
help
virion
particl
trespass
membran
mechan
use
anim
virus
enter
cell
deliv
genom
cytoplasm
subject
intens
research
hoekstra
kok
marsh
heleniu
anim
virus
contain
lipid
membran
accomplish
task
fusion
extern
envelop
cellular
membran
involv
either
plasma
membran
occur
sendai
viru
herpesviru
vaccinia
viru
endosom
membran
case
semliki
forest
viru
sfv
vesicular
stomat
viru
vsv
influenza
viru
hoekstra
kok
marsh
heleniu
latter
case
fusion
promot
conform
modif
viral
glycoprotein
receptor
bind
acidif
endosom
wiley
skehel
white
prevent
acidif
lysosomotrop
agent
lead
inhibit
infect
sfv
vsv
influenza
viru
hoekstra
kok
model
explain
entri
anim
viru
particl
devoid
lipid
envelop
picornavirus
scarc
hoekstra
kok
marsh
heleniu
principl
virus
could
pass
directli
plasma
membran
receptor
bind
evid
support
mode
entri
certain
virus
adenovirus
brown
burlingham
polioviru
dunneback
et
al
rotavirus
kaljot
et
al
reoviru
subvir
particl
borsa
et
al
altern
viral
particl
intern
receptormedi
endocytosi
cross
endosom
membran
everaert
et
al
marsh
helenu
kronenberg
et
al
case
viral
genom
must
pass
across
lipid
membran
aid
virion
protein
evid
indic
major
nake
anim
viru
particl
follow
receptormedi
endocytosi
pathway
infect
cell
marsh
heleniu
whether
virus
need
low
ph
step
trigger
cross
endosom
membran
enter
cell
phindepend
mechan
remain
open
debat
brown
burlingham
madshu
et
al
svensson
sturzenbeck
et
al
gromeier
wetz
kronenberg
et
al
varga
et
al
two
major
question
therefor
remain
answer
respect
mechan
picornaviru
entri
cell
given
picornaviru
speci
intern
endosom
particular
cell
type
endosom
need
acidifi
viru
enter
cell
attach
polioviru
intern
endosom
lead
conform
chang
virion
particl
particularli
frick
hogl
allow
interact
membran
aid
insert
myristoyl
protein
membran
lonberg
holm
et
al
guttman
baltimor
frick
hogl
insert
destabil
particl
may
also
allow
interact
membran
moieti
viral
protein
lonberg
holm
et
al
guttman
baltimor
frick
hogl
fig
specul
insert
virion
protein
membran
would
open
pore
genom
deliv
altern
energi
may
requir
form
atp
protonmot
membran
potenti
andor
ph
gradient
gener
endosom
activ
protonatpas
pump
could
use
drive
nucleocapsid
lipid
barrier
membran
simpl
mechanist
model
viral
particl
open
pore
membran
genom
pass
howev
inconsist
fact
uncoat
per
se
occur
vitro
presenc
receptor
hooverlitti
greve
wherea
entri
genom
cytoplasm
requir
metabol
activ
cell
hoekstra
kok
marsh
heleniu
presenc
ion
channel
icosahedr
viru
particl
kalko
et
al
may
indic
insert
capsid
membran
open
ion
channel
requir
dissip
ionic
gradient
endosom
cytoplasm
fig
two
potenti
rout
picornaviru
entri
cell
coentri
toxin
ctsarcin
viral
particl
bind
receptor
follow
endosom
rout
direct
entri
plasma
membran
proton
gradient
gener
vacuolar
protonatpas
use
virion
protein
transloc
tsarcin
vacuolar
membran
one
approach
toward
understand
mechan
anim
virus
travers
cellular
membran
elucid
molecular
term
coentri
protein
toxin
macromolecul
viral
particl
achiev
yamaizumi
et
al
fernhndezpuent
carrasco
fitzgerald
et
al
carrasco
et
al
infect
suscept
cell
picornavirus
lead
profound
chang
membran
permeabl
two
welldefin
period
infect
cycl
earli
infect
viru
enter
cell
begin
late
phase
onset
viral
macromolecular
synthesi
take
place
review
see
carrasco
et
al
late
modif
membran
permeabl
also
known
late
membran
leaki
carrasco
carrasco
et
al
molecular
basi
underli
phenomena
differ
thu
virion
particl
necessari
accomplish
increas
membran
permeabl
earli
infect
fernfindezpuent
carrasco
carrasco
wherea
viral
gene
express
necessari
develop
late
membran
leaki
carrasco
contrera
carrasco
select
compound
develop
block
replic
anim
virus
earli
late
modif
membran
carrasco
vazquez
fernfindezpuent
first
observ
viral
particl
permeabil
cell
protein
toxin
otherwis
unabl
cross
membran
receptor
protein
effici
deliv
cytoplasm
shortli
addit
picornaviru
medium
inde
almost
cell
becom
permeabil
minut
otero
carrasco
lee
et
al
suggest
viral
particl
contain
compon
promot
entri
viral
nucleocapsid
cell
also
direct
macromolecul
physic
bound
particl
toward
cytoplasm
fig
know
differ
protein
toxin
cross
membran
presenc
anim
viru
particl
protein
luciferas
horseradish
peroxidas
otero
carrasco
polysaccharid
gonzfilez
et
al
also
deliv
cell
particl
fig
infecti
virion
requir
earli
membran
permeabil
occur
phenomenon
take
place
uvinactiv
heatinactiv
virion
carrasco
otero
carrasco
carrasco
et
al
recent
permeabil
cell
adenoviru
particl
use
introduc
dna
cell
seri
eleg
experi
birnsteil
colleagu
shown
plasmid
bind
cell
complex
transferrinpolylysin
molecul
zenk
et
al
wagner
et
al
entri
complex
enhanc
adenoviru
particl
present
cultur
medium
fashion
cell
express
transfect
gene
wagner
et
al
b
zatlouk
et
al
start
understand
exact
mechan
earli
membran
permeabil
membran
induc
viral
particl
occur
certainli
receptor
bind
polioviru
particl
virion
uncoat
necessari
process
take
place
almela
et
al
specul
deliveri
protein
toxin
anim
virus
involv
disrupt
endosom
fitzgerald
et
al
carrasco
et
al
select
mechan
possibl
effect
protein
synthesi
ad
uninfect
hela
cell
wherea
toxin
effici
block
translat
ad
togeth
virion
particl
fernmdezpuent
carrasco
otero
carrasco
cointern
protein
toxin
polioviru
potent
block
bafilomycin
al
see
section
concentr
prevent
infect
sfv
vsv
carrasco
result
indic
activ
vacuolar
protonatpas
necessari
effici
deliveri
cytoplasm
mediat
polioviru
particl
may
conclud
toxin
deliv
cytoplasm
come
endosom
entri
inhibit
hela
cell
tsarcin
total
prevent
inhibit
vacuolar
protonatpas
bfla
carrasco
model
polioviru
entri
illustr
coentri
tsarcin
site
action
differ
inhibitor
discuss
section
polioviru
enter
endosom
cytoplasm
endosom
membran
remain
intact
ruptur
would
lead
erupt
endosom
content
includ
ctsarcin
cytoplasm
although
polioviru
permeabil
cell
gsarcin
event
occur
endosom
conceiv
although
unlik
viru
alreadi
releas
genom
cytoplasm
bind
cell
surfac
receptor
virion
protein
present
membran
intern
endosom
one
control
permeabil
gsarcin
fig
thu
simpl
idea
envelop
anim
virus
enter
cell
fusion
two
membran
marsh
heleniu
perhap
unten
model
explain
cointern
macromolecul
take
place
yamaizumi
et
al
fitzgerald
et
al
carrasco
et
al
lee
et
al
perhap
protonmot
forc
use
drive
viral
nucleocapsid
macromolecul
lipid
barrier
membran
virion
protein
may
coupl
energi
liber
atp
hydrolysi
movement
proton
ion
cytoplasm
favour
gradient
transloc
genom
protein
toxin
direct
carrasco
et
ai
compound
bind
viru
protitl
indic
section
surfac
virion
particl
rhinovirus
polioviru
canyon
cross
protom
rossman
rossmann
johnson
harber
wimmer
canyon
hydrophob
pocket
within
flbarrel
number
compound
block
virion
uncoat
bind
see
review
diana
et
al
rossman
rossmann
johnson
mckinlay
et
al
fig
bind
increas
protein
rigid
stabil
particl
manner
uncoat
proceed
rossmann
chapman
et
al
gruenberg
et
al
mckinlay
et
al
fig
thu
uncoat
inhibitor
act
stapl
virion
particl
stabil
block
disassembl
virus
refin
studi
uncoat
inhibitor
carri
seri
compound
develop
sterlingwinthrop
collect
refer
win
compound
fig
rossmann
mckinlay
et
al
current
knowledg
interact
antivirai
agent
rhinoviru
particl
laid
groundwork
computerassist
drug
design
one
earliest
step
picornaviru
uncoat
format
particl
sediment
coeffici
lost
lonberg
holm
et
al
guttman
baltimor
particl
form
infect
cell
picornavirus
vitro
exposur
virion
variou
treatment
eg
alter
ionic
condit
ph
giranda
et
al
format
particl
vivo
vitro
block
win
compound
fox
et
al
zeichhardt
et
al
gruenberg
et
al
studi
human
rhinoviru
particl
atom
resolut
rossmann
et
al
aid
elucid
mode
interact
number
win
compound
particl
badger
et
al
badger
et
al
rossmann
rossmann
kim
et
al
kim
et
al
diana
et
al
mckinlay
et
al
bind
site
antivir
agent
hydrophob
pocket
locat
beneath
canyon
floor
rossmann
diana
et
al
chapman
et
al
mckinlay
et
al
kim
et
al
see
fig
bind
drug
pocket
induc
conform
chang
floor
canyon
caus
push
upward
deform
interfer
bind
rhinoviru
serotyp
receptor
although
rhinoviru
serotyp
polioviru
inhibit
win
compound
respect
interact
cell
surfac
receptor
fox
et
al
zeichhardt
et
al
almela
et
al
thu
rhinoviru
serotyp
would
block
bind
uncoat
step
shepard
et
al
wherea
inhibit
picornavirus
drug
would
uncoat
step
fox
et
al
zeichhardt
et
al
pevear
et
al
almela
et
al
rhinoviru
poliovirus
contrast
rhinovirus
bind
cofactor
lipid
natur
pocket
underneath
canyon
floor
filman
et
al
yeat
et
al
kim
et
al
cofactor
displac
bind
win
compound
without
alter
floor
canyon
kim
et
al
observ
may
explain
attach
virion
particl
case
rhinoviru
polioviru
block
win
compound
kim
et
al
number
clinic
trial
common
cold
use
compound
bind
rhinoviru
particl
block
uncoat
carri
tyrrel
barrow
et
al
mckinlay
et
al
although
result
dichloroflavan
ro
rp
disappoint
recent
trial
win
r
r
promis
see
one
major
problem
therapeut
treatment
common
cold
reach
drug
level
nasal
epithelium
suffici
high
block
viral
growth
reed
tyrreu
win
disoxaril
one
first
win
compound
evalu
therapeut
see
develop
new
deriv
broader
spectrum
action
increas
potenc
rhinoviru
prompt
clinic
evalu
win
effect
rhinoviru
administ
oral
group
volunt
turner
et
al
howev
prophylact
trial
common
cold
caus
coxsacki
viru
demonstr
oral
efficaci
compound
mckinlay
et
al
schiff
et
al
arildon
win
disoxaril
win
fig
also
belong
group
win
compound
arildon
select
inhibitor
polioviru
uncoat
mcsharri
et
al
caliguiri
et
al
mcsharri
pancic
egger
rosenwirth
everaert
et
al
arildon
relat
deriv
block
replic
sever
rna
dna
virus
includ
herp
simplex
viru
type
diana
et
al
b
kuhrt
et
al
cytomegaloviru
sfv
vsv
kim
et
al
administr
radioact
arildon
mice
dog
monkey
variou
rout
indic
extens
metabol
benzig
edelson
arildon
isoxazol
activ
administ
oral
mice
inocul
intracerebr
polioviru
type
diana
et
al
isoxazol
activ
rhinoviru
type
cultur
cell
diana
et
al
disoxaril
phenoxi
broad
spectrum
antipicornavir
agent
diana
et
al
b
mckinlay
otto
et
al
oral
administr
win
effect
echoviru
prevent
poliovirusinduc
paralysi
death
mice
mckinlay
mckinlay
steinberg
mckinlay
rossmann
strain
polioviru
type
caus
persist
infect
cn
immunosuppress
mice
disoxazil
treatment
mice
significantli
decreas
incid
diseas
induc
rapid
clearanc
viru
cn
jubelt
et
al
unfortun
side
effect
appear
patient
high
oral
dose
compound
given
compound
belong
seri
pyridazinamin
analogu
synthes
janssen
research
foundat
fig
block
replic
differ
rhin
viru
serotyp
stabil
viral
particl
inhibit
uncoat
andri
et
al
rombaut
et
al
intern
polioviru
particl
cell
affect
r
wherea
uncoat
releas
particl
cytosol
block
rombaut
et
al
oforianyinam
et
al
assum
agent
directli
inactiv
viral
particl
andri
et
al
mutant
resist
r
crossresist
antivir
agent
includ
win
like
agent
bind
hydrophob
pocket
locat
beneath
canyon
human
rhinovirus
use
win
compound
chapman
et
al
direct
evid
interact
obtain
xray
crystallograph
analysi
human
rhinoviru
complex
r
chapman
et
al
agent
bind
toward
pocket
entranc
fail
occupi
end
pocket
chapman
et
al
suggest
ad
tail
r
fit
end
pocket
would
improv
drug
activ
rhinoviru
chapman
et
al
clinic
efficaci
common
cold
first
demonstr
r
pirodavir
hayden
et
al
administr
r
appli
nasal
spray
hydroxyflcyclodextrin
vehicl
human
volunt
infect
rhinoviru
show
efficaci
given
prophylact
use
therapeut
ainakib
et
al
barrow
et
al
sch
hexyl
imidazol
hydrochlorid
fig
watersolubl
antivir
agent
bind
irrevers
enteroviru
rhinoviru
particl
zhang
et
al
structur
rhinoviru
complex
sch
show
compound
bind
innermost
end
hydrophob
pocket
vp
leav
entranc
unoccupi
interact
induc
conform
chang
involv
stretch
least
amino
acid
zhang
et
al
power
et
al
torney
et
al
number
phenoxybenzen
phenoxypyridin
synthes
evalu
antivir
activ
kenni
et
al
among
compound
found
broadspectrum
antivir
activ
kenni
et
al
best
antipicornaviru
activ
found
ethylthio
carbonitril
depc
kenni
et
al
uncoat
photosensit
coxsacki
viru
reduc
compound
kenni
et
al
furthermor
depc
recent
shown
block
uncoat
step
polioviru
gonzhlez
et
al
almela
et
al
seri
pyridin
synthes
kenni
et
ai
mdl
mdl
dl
fig
show
potent
antirhinoviru
activ
kenni
et
al
substitut
coupl
requir
strong
inhibit
compound
inhibit
rhinoviru
growth
concentr
ngml
kenni
et
al
studi
mode
action
indic
mdl
bind
directli
rhinoviru
particl
block
uncoat
kenni
et
al
number
flavan
deriv
fig
synthes
assay
rhinoviru
type
bauer
et
al
tisdal
selway
concentr
nm
ddichloroflavan
block
replic
rhinoviru
cultur
cell
make
compound
time
activ
inhibitor
rhinoviru
cultur
system
tisdal
selway
recent
isoxazol
shown
activ
diana
et
al
clinic
trial
given
oral
intranas
fail
protect
rhinoviru
infect
despit
fact
drug
achiev
good
blood
level
given
oral
howev
could
found
nasal
secret
phillpott
et
al
alnakib
et
al
radioact
bind
rhinoviru
particl
act
earli
step
infect
bauer
et
al
tisdal
selway
sever
base
synthes
give
good
inhibit
rhinovirus
also
picornavirus
desideri
et
al
final
contain
lipophil
para
substitu
good
inhibitor
rhinoviru
kelley
et
al
ro
fig
activ
compound
rhinovirus
bind
viral
capsid
ishitsuka
et
al
b
ninomiya
et
al
radioact
chalcon
ro
bind
specif
rhinoviru
particl
bind
inhibit
ninomiya
et
al
ishitsuka
et
al
rhinoviru
serotyp
test
inhibit
ro
ishitsuka
et
al
mutant
rhinovirus
resist
chalcon
crossresist
ishitsuka
et
al
result
indic
three
compound
similar
mode
action
base
bind
virion
particl
sever
analogu
ro
synthes
time
activ
parent
compound
ninomiya
et
al
administr
ngml
ro
suffici
significantli
reduc
rhinoviru
replic
cultur
cell
ninomiya
et
al
analogu
bind
site
viru
particl
ro
similar
mode
action
ninomiya
et
al
rp
rp
acet
acid
fig
show
select
antirhinoviru
activ
zerial
et
al
activ
concentr
lower
caus
cytotox
effect
gml
compound
virucid
act
earli
step
infect
zerial
et
al
block
uncoat
virion
particl
et
al
rhodanin
fig
select
inhibit
uncoat
echoviru
type
egger
adsorpt
virion
cell
subsequ
entri
cytoplasm
affect
compound
picornavirus
rnaor
dnacontain
virus
suscept
inhibit
rhodanin
compound
deleteri
effect
cell
morpholog
cellular
macromolecular
synthesi
egger
egger
et
al
rosenwirth
egger
protect
virion
alkalin
degrad
egger
heatinactiv
rosenwirth
egger
rhodanin
appar
block
uncoat
sinc
compound
prevent
shutoff
host
protein
synthesi
induc
echoviru
rosenwirth
egger
well
establish
inhibit
host
translat
picornavirus
requir
translat
input
genom
rna
step
take
place
presenc
uncoat
inhibitor
rmi
ethanon
fig
directli
inactiv
rhinoviru
particl
ash
et
al
mode
action
agent
still
investig
detail
possibl
compound
block
uncoat
ninomiya
et
al
may
effect
activ
cell
pretreat
wash
agent
ad
hr
infect
ash
et
al
chemic
structur
rmi
similar
tetradecyloxi
lfuroic
acid
tofa
inhibitor
polioviru
genom
replic
see
section
sever
agent
interact
picornaviru
particl
stabil
heatinactiv
andor
decapsid
case
lcystin
amino
acid
pohjanpelto
glutathion
fenwick
cooper
steel
black
methylthiopyrimidin
deriv
fig
yamazi
et
al
la
colla
et
al
lonberg
holm
et
al
treatment
polioviru
mm
result
direct
inactiv
infect
perhap
oxid
form
compound
react
sulfhydryl
group
capsid
protein
inactiv
steel
black
inhibit
thermal
inactiv
polioviru
particl
decapsid
hela
cell
lonberg
holm
et
al
inhibit
viru
attach
receptor
result
block
viral
growth
lentz
inhibit
achiev
sever
mean
one
use
antibodi
viral
particl
block
interact
receptor
anoth
approach
antagon
receptor
antibodi
direct
receptor
minor
et
al
colonno
et
al
minor
minor
applic
latter
approach
human
volunt
infect
rhinoviru
delay
onset
symptom
diseas
infect
hayden
et
al
final
antiidiotyp
antibodi
direct
virion
viral
receptor
antibodi
also
inhibit
viral
infect
lentz
anoth
approach
block
polioviru
rhinoviru
infect
use
solubl
receptor
ie
moieti
receptor
molecul
devoid
carboxi
terminu
respons
anchor
molecul
membran
kaplan
et
al
b
marlin
et
al
hooverlitti
greve
incub
viru
particl
receptor
truncat
solubl
receptor
lead
format
complex
select
inhibit
infect
kaplan
et
al
b
marlin
et
al
hooverlitti
greve
chimer
molecul
immunoglobulin
effect
inhibit
rhinoviru
bind
cell
martin
et
al
util
approach
attack
viral
infect
organ
limit
sinc
exampl
mutant
virus
resist
neutral
receptor
readili
aris
kaplan
et
al
amin
thought
accumul
endosom
organel
vesicular
system
becom
proton
accordingli
permeat
less
readili
thu
caus
rise
endosom
ph
fletcher
et
al
seglen
contrast
monensin
nigericin
fig
ionophor
exchang
na
favour
h
gradient
thu
dissip
ph
gradient
creat
protonatpas
pump
seglen
indic
principl
two
possibl
mechan
polioviru
entri
ie
direct
entri
plasma
membran
dunneback
et
al
intern
endosom
zeichhardt
et
al
polioviru
might
use
mechan
differ
cell
type
even
kind
cell
viral
particl
endosom
must
exit
organeil
order
initi
translat
genom
rna
cytoplasm
still
matter
debat
whether
polioviru
requir
acidif
endosom
allow
passag
genom
endosom
membran
madshu
et
al
c
zeichhardt
et
al
polioviru
accomplish
task
phindepend
fashion
gromeier
wetz
prez
carrasco
indirect
experi
involv
complex
polioviru
particl
neutral
red
prior
incub
sever
minut
weak
amin
monensin
follow
long
incub
led
suggest
polioviru
requir
lowph
step
infect
madshu
et
al
c
viru
entri
evalu
measur
cytopath
effect
caus
polioviru
complex
neutral
red
sever
round
viral
replic
madshu
et
al
c
high
concentr
amin
also
use
eg
mm
chloroquin
mm
zeichhardt
et
al
polioviru
polymeras
product
strongli
inhibit
even
compound
ad
hr
viru
entri
zeichhardt
et
al
certainli
lysosomotrop
agent
employ
number
side
effect
influenc
varieti
enzym
function
apart
rais
endosom
ph
seglen
hiebsch
et
al
henc
surpris
long
incub
time
sever
round
viral
replic
take
place
inhibit
viru
madshu
et
al
c
shorter
incub
time
test
inhibit
polioviru
chloroquin
monensin
uncoat
period
lead
idea
polioviru
entri
phindepend
gromeier
wetz
carrasco
presenc
lysosomotrop
agent
chloroquin
amantadin
dansylcadaverin
monensin
polioviru
entri
inhibit
infect
prez
carrasco
studi
requir
lowph
step
entri
member
picornavirida
famili
indic
replic
fmdv
inhibit
lysosomotrop
compound
carrillo
et
al
carrillo
et
al
baxt
direct
action
agent
initi
step
viru
infect
still
uncertain
howev
chloroquin
still
activ
inhibit
fmdv
replic
even
ad
hr
infect
baxt
wherea
monensin
neubauer
et
al
well
prez
carrasco
block
intern
label
rhinoviru
particl
hela
cell
claim
monensin
might
even
increas
infect
cell
emc
viru
lowph
medium
use
viru
penetr
madshu
et
al
entri
emc
viru
hela
cell
inhibit
increas
ph
endosom
prez
carrasco
fig
chemic
structur
differ
compound
bafilomycin
ai
monensin
chloroquin
nigericin
ho
nigericin
produc
organ
molecular
mass
mw
number
amino
acid
aa
mode
action
indic
three
major
class
protonatpas
exist
mammalian
cell
mitochondri
fclass
atpas
plasma
membran
proton
atpas
pclass
vclass
vacuolar
protonatpas
schneider
nelson
taiz
class
distinguish
sever
paramet
includ
sensit
inhibitor
nelson
taiz
endosom
along
organel
vesicular
system
becom
acidifi
action
vacuolar
protonatpas
schneider
nelson
taiz
enzym
pump
proton
organel
expens
atp
hydrolysi
schneider
nelson
taiz
two
major
class
inhibitor
hitherto
use
assess
requir
lowph
step
viru
infect
either
weak
amin
chloroquin
amantadin
etc
rais
endosom
ph
accumul
ionophor
monensin
nigericin
dissip
proton
gradient
seglen
see
section
studi
inhibitor
dicyclohexylcarbodiimid
dccd
block
type
protonatpas
assay
seglen
hiebsch
et
al
fig
recent
discov
antibiot
power
select
inhibitor
vacuolar
protonatpas
bowman
et
al
nelson
taiz
zeuzem
et
al
et
al
contrast
dccd
nonspecificauy
block
type
protonatpas
nelson
taiz
uniqu
compound
assay
role
acidif
endosom
action
vacuolar
protonatpas
play
entri
anim
virus
virus
sfv
vsv
enter
cell
endosom
need
acidif
potent
inhibit
wherea
polioviru
infect
affect
antibiot
prrez
therefor
entri
polioviru
restrict
three
differ
techniqu
use
increas
endosom
ph
ie
blockad
vacuolar
protonatpas
rais
endosom
ph
weak
amin
dissip
ph
gradient
monensin
effect
bfla
member
picornavirida
famili
indic
entri
emc
viru
hela
cell
affect
macrolid
antibiot
wherea
rhinoviru
sensit
action
prrez
coentri
toxin
asarcin
togeth
polioviru
particl
potent
inhibit
indic
activ
vacuolar
protonatpas
necessari
earli
membran
permeabil
induc
polioviru
see
section
number
protein
toxin
effect
inhibitor
protein
synthesi
vtzquez
jimenez
vtzquez
tabl
mode
action
toxin
intact
cell
involv
two
step
name
attach
toxin
cell
membran
receptor
entri
toxin
effector
moieti
cytoplasm
enzymat
inactiv
compon
protein
synthes
machineri
occur
toxin
diphtheria
pseudomona
exotoxin
inactiv
elong
factor
adpribosyl
aktori
wherea
ricin
abrin
ctsarcin
mitogillin
etc
inactiv
ribosom
act
rrna
endo
tsurugi
hartley
et
al
better
et
al
irvin
uckun
plant
toxin
mitogillin
restrictocin
ctsarcin
bind
receptor
potent
inhibitor
translat
cellfre
system
permeabil
cell
jimenez
vtzquez
carrasco
vizquez
polioviru
abl
cointern
thu
deliv
protein
toxin
effici
cell
carrasco
carrasco
et
al
lee
et
al
almela
et
al
antivir
potenc
toxin
high
toxin
enter
along
infect
viru
translat
viral
protein
occur
format
progeni
viru
strongli
suppress
usseri
et
al
yamaizumi
et
al
fernandezpuent
carrasco
carrasco
carrasco
esteban
irvin
uckun
addit
protein
toxin
low
molecular
weight
antibiot
also
enter
cell
earli
infect
carrasco
carrasco
vizquez
gener
hydrophil
antibiot
select
inhibitor
viral
translat
carrasco
vizquez
thu
block
viral
replic
concentr
affect
uninfect
cell
lacal
carrasco
see
also
section
mode
action
differ
inhibitor
entri
polioviru
coentri
toxin
illustr
fig
picornaviru
possess
singl
speci
mrna
ident
genom
long
rna
kb
singl
initi
aug
except
fmdv
initi
take
place
two
differ
aug
phase
direct
synthesi
two
differ
l
protein
belsham
picornaviru
rna
accomplish
host
protein
synthes
machineri
use
gener
mechan
use
translat
cellular
mrna
particularli
respect
elong
termin
phase
howev
initi
translat
picornaviru
rna
show
unusu
featur
consid
known
cellular
mrna
possess
cap
structur
recogn
translat
initi
complex
rhoad
rhoad
ribosom
subunit
plu
number
initi
factor
bound
cap
scan
mrna
leader
sequenc
aug
found
correct
context
start
translat
sonenberg
kozak
mechan
use
initi
picornaviru
translat
initi
complex
bind
uniqu
intern
sequenc
within
long
leader
sequenc
sonenberg
polioviru
region
locat
approxim
nucleotid
leader
sequenc
sonenberg
kozak
secondari
structur
leader
region
differ
picornavirus
reveal
two
differ
pattern
one
enteroand
rhinovirus
anoth
cardioand
aphtovirus
jang
et
al
pelleti
sonenberg
belsham
harber
wimmer
fig
even
possibl
requir
mechan
initi
rna
two
class
virus
differ
thu
initi
translat
polioviru
mrna
start
attach
initi
complex
intern
region
leader
sequenc
christen
ribosom
land
pad
rlp
intern
ribosom
entri
site
ire
event
could
follow
scan
phase
select
initi
aug
sonenberg
kozak
contrast
initi
emc
viru
rna
commenc
direct
bind
initi
complex
ire
rlp
initi
aug
scan
phase
appear
involv
sinc
picornaviru
rna
high
bind
affin
ribosom
exhibit
differ
requir
translat
respect
initi
factor
picornaviru
rna
first
mammalian
mrna
translat
cellfre
system
kerr
martin
studi
show
translat
requir
differ
concentr
initi
factor
compar
translat
cellular
mrna
wigl
smith
recent
studi
analyz
effect
exogen
ad
individu
initi
factor
rabbit
retieulocyt
lysat
program
cap
uncap
mrna
intern
initi
synthet
bicistron
mrna
contain
polioviru
second
cistron
increas
addit
anthoni
merrick
indic
particip
translat
natur
uncap
mrna
anthoni
merrick
thoma
et
al
apart
initi
factor
requir
effici
translat
number
cellular
protein
bind
affin
picornaviru
rna
identifi
role
protein
could
play
intern
initi
translat
initi
correct
factor
deserv
investig
viral
protein
also
bind
specif
region
mrna
perhap
might
affect
translat
case
polioviru
protein
bind
andino
et
al
protein
enhanc
translat
polioviru
rna
yet
unidentifi
mechan
hambidg
sarnow
one
interest
aspect
translat
picornaviru
rna
comparison
cellular
mrna
requir
higher
concentr
monoval
cation
optim
translat
carrasco
smith
fact
ionic
condit
requir
initi
translat
effici
picornaviru
rna
initi
cellular
mrna
restrict
saborio
et
al
carrasco
smith
carrasco
et
al
discrimin
viral
cellular
mrna
shown
monoval
cation
cellfre
system
higher
cation
concentr
result
effect
perfectli
mimic
shutoff
host
translat
observ
intact
cell
infect
carrasco
smith
physiolog
signific
requir
relat
fact
viral
protein
synthesi
take
place
mainli
cytoplasm
monoval
ion
concentr
drastic
chang
see
review
carrasco
et
al
consequ
membran
leaki
produc
picornaviru
infect
observ
explain
shutoff
host
translat
infect
observ
member
picornavirida
famili
carrasco
carrasco
carrasco
castrillo
picornavirus
encod
proteas
respons
process
polyprotein
produc
matur
viral
protein
krausslich
hellen
et
al
lawson
semler
palmenberg
picornaviru
proteas
classifi
cystein
peptidas
rawl
barrett
two
polioviru
proteas
protein
activ
precursor
form
abl
cleav
substrat
cs
inde
proteolyt
modif
recogn
substrat
tran
even
nascent
polypeptid
chain
viral
proteas
highli
specif
interchang
differ
picornaviru
speci
hellen
et
al
lawson
semler
palmenberg
apart
cleav
viral
polyprotein
polypeptid
precursor
also
cleav
limit
number
cellular
protein
grigera
tisminetzki
urzhinqui
carrasco
falk
et
al
clark
et
al
joachim
etchison
best
illustr
exampl
cleavag
polypeptid
form
part
translat
initi
factor
induc
polioviru
proteas
etchison
et
al
lloyd
et
al
cleavag
directli
accomplish
anoth
cellular
proteas
activ
wyckoff
et
al
wyckoff
et
al
suggest
cleavag
crucial
step
inhibit
host
translat
polioviru
infect
etchison
et
al
howev
recent
evid
indic
may
thu
correl
time
cleavag
shutoff
host
translat
etchison
et
al
bonneau
sonenberg
ptrez
carrasco
presenc
inhibitor
polioviru
rna
synthesi
allow
complet
cleavag
hour
still
substanti
amount
host
protein
synthesi
bonneau
sonenberg
ptrez
carrasco
translat
sever
cap
viral
mrna
take
place
poliovirusinfect
cell
alonso
carrasco
ufioz
et
al
castrillo
carrasco
schrader
westaway
initi
factor
togeth
form
local
nucleu
cytoplasm
lejbkowicz
et
al
monocyt
cell
line
persist
infect
polioviru
synthes
protein
even
though
extens
complet
degrad
lloyd
bove
polioviru
mutant
unabl
cleav
still
shut
host
translat
bernstein
et
al
stimul
translat
cap
natur
uncap
viral
mrna
anthoni
merrick
thoma
et
al
transient
express
polioviru
protein
proteas
induc
cleavag
major
impact
transcript
report
gene
compar
translat
final
disrupt
yeast
gene
homologu
block
cellular
growth
lanker
et
al
precis
action
picornaviru
proteas
vital
gener
matur
viral
protein
turn
requir
number
viral
process
includ
replic
picornaviru
genom
krausslich
hellen
et
al
lawson
semler
palmenberg
thu
seem
feasibl
select
interfer
proteas
function
would
lead
specif
inhibit
viral
growth
korant
et
al
hellen
wimmer
inde
number
agent
describ
inhibitor
proteas
function
korant
et
al
korant
korant
korant
broadli
classifi
two
categori
compound
modifi
conform
viral
polyprotein
render
refractori
proteas
action
inhibitor
proteas
respect
first
categori
number
amino
acid
analogu
jacobson
et
al
jacobson
baltimor
zinc
ion
korant
et
al
high
temperatur
lead
conform
chang
polioviru
polyprotein
longer
recogn
viral
proteas
korant
korant
howev
approach
select
inhibit
viral
proteas
sinc
cellular
protein
also
affect
number
amino
acid
analogu
use
inhibit
proteolyt
degrad
picornaviru
polyprotein
fact
agent
employ
identifi
picornaviru
precursor
block
format
matur
protein
compound
dlethionin
brown
ackermann
tpck
tolylsulfonylphenylalanyl
chloromethyl
keton
tlck
tolylsulfonyl
lysyl
chloromethyl
keton
korant
zpck
carbobenzyloxyphenylalanyl
chloromethyl
keton
summer
et
al
zlck
carbobenzoxyleucyl
chloromethyl
keton
korant
et
al
canavanin
fluorophenylalanin
brown
et
al
levintow
et
al
scharff
levintow
fig
inhibit
proteolyt
process
picornaviru
polyprotein
activ
cystein
proteas
control
set
protein
inhibitor
constitut
cystatin
superfamili
protein
cystatin
c
human
cystein
proteinas
inhibitor
present
extracellular
fluid
cystatin
small
protein
amino
acid
bind
select
inhibit
cystein
proteas
human
cystatin
c
obtain
human
serum
human
stefin
b
obtain
spleen
also
bind
inhibit
polioviru
proteas
block
replic
polioviru
cultur
cell
korant
et
al
korant
et
al
cystatin
c
also
peptid
mimic
proteinasebind
center
cystatin
c
zlvgchnhz
nbenzyloxycarbonylleucylvalylglycin
diazomethylketon
show
antivir
activ
polioviru
herp
simplex
viru
see
section
bjorck
et
al
use
peptid
mimic
viral
cleavag
site
provid
potenti
develop
new
proteas
inhibitor
inhibit
proteas
function
green
shaw
therefor
analogu
recognit
site
viral
proteas
modifi
ctermin
ntermin
block
viral
replic
bjorck
et
al
korant
tri
tetraor
pentapeptid
ctermin
chloromethyl
keton
methyl
keton
moieti
activ
polioviru
rhinoviru
kettner
korant
thiol
proteas
inhibitor
fig
natur
product
isol
aspergillu
japonicu
also
chemic
synthes
leupeptin
inhibitor
cystein
proteas
calpain
mehdi
deriv
lack
charg
group
inhibit
intracellular
proteas
mehdi
specif
block
lproteas
fmdv
lead
reduct
viru
yield
kleina
grubman
addit
permeabl
analogu
cultur
cell
infect
fmdv
decreas
viral
rna
synthesi
cleavag
retard
virusinduc
shutoff
host
translat
kleina
grubman
yet
known
whether
last
effect
due
inhibit
lproteas
gener
retard
viral
replic
permeabl
deriv
nontox
anim
dose
mgkg
bodi
weight
well
toler
variou
administr
rout
komatsu
et
al
kleina
grubman
seri
spiro
indolinon
fllactam
synthes
activ
assay
polioviru
rhinoviru
proteas
skile
mcneil
sulfonamid
deriv
shown
fig
activ
picornaviru
proteas
cellular
proteas
human
leukocyt
elastas
cathepsin
g
skile
mcneil
thysanon
fig
novel
naphthoquinon
isol
fungu
thysanophora
penicilloid
activ
rhinoviru
proteas
singh
et
al
select
compound
cell
cultur
yet
investig
although
viral
proteas
repeatedli
suggest
potenti
effect
target
inhibit
viral
growth
korant
hellen
wimmer
clinic
result
report
support
premis
drastic
modif
membran
permeabl
occur
late
phase
replic
cycl
mani
cytolyt
virus
detail
review
subject
alreadi
publish
fig
major
salient
featur
viral
gene
product
requir
develop
late
modif
membran
permeabl
modif
start
hela
cell
third
hour
infect
polioviru
nair
et
al
lacal
carrasco
mufioz
carrasco
nair
et
al
garri
second
hour
pi
cell
infect
sfv
garri
et
al
ulug
et
al
thu
major
viral
macromolecul
synthes
cell
alter
plasma
membran
cytoplasm
concentr
ion
perhap
ph
dival
cation
gradual
chang
carrasco
smith
mufioz
et
al
b
et
al
holsey
et
al
mechan
membran
permeabil
polioviru
fairli
well
understood
overal
increas
permeabl
varieti
molecul
modif
membran
gradient
monoval
cation
destroy
addit
metabolit
compound
exclud
membran
leak
cell
readili
pass
cytoplasm
egbert
et
al
benedetto
et
al
nair
updat
view
modif
membran
permeabl
anim
virus
shown
fig
put
viral
protein
respons
membran
modif
associ
membran
synthes
travel
vesicular
system
plasma
membran
alreadi
indic
viral
protein
may
possess
ionophorelik
activ
carrasco
carrasco
carrasco
et
al
ph
ionic
content
vesicl
vesicular
system
modifi
protein
reach
plasma
membran
increas
permeabl
ion
lead
disrupt
membran
potenti
carrasco
suggest
chang
ion
ph
cytoplasm
influenc
array
cellular
function
includ
translat
host
mrna
carrasco
carrasco
carrasco
et
al
respect
mechan
late
membran
permeabil
found
phospholipas
activ
inhibit
earli
follow
polioviru
infect
wherea
phospholipas
c
hydrolys
phosphatidylinositol
stimul
third
hour
pi
guinea
et
al
thu
poliovirusinfect
cell
amount
inositol
triphosph
present
cytoplasm
constantli
increas
guinea
et
al
increas
would
lead
augment
free
calcium
howev
awar
analysi
free
calcium
level
cell
infect
picornavirus
recent
analyz
detail
activ
phospholipas
c
hydrolys
phosphatidylcholin
found
cholin
phosphorylcholin
drastic
increas
medium
poliovirusinfect
cell
third
hour
infect
clear
correl
time
exist
increas
membran
permeabl
activ
phospholipas
c
poliovirusinfect
cell
guinea
et
al
irurzun
et
al
howev
know
yet
causeeffect
relationship
number
protein
toxin
melittin
modifi
membran
permeabl
also
activ
phospholipas
activ
durkin
shier
pellkof
et
al
tempt
specul
polioviru
encod
protein
respons
modifi
membran
lama
carrasco
b
lama
et
al
protein
could
polioviru
protein
membran
protein
contain
amphipath
helix
similar
motif
found
viral
membran
protein
modifi
membran
permeabl
pinto
et
al
carrasco
et
al
viral
protein
respons
increas
membran
permeabl
collect
refer
viroporin
accumul
suffici
number
copi
viroporin
would
form
pore
membran
may
lead
per
se
permeabil
membran
secondari
effect
could
activ
phospholipas
c
gener
diacylglycerol
turn
also
increas
membran
permeabl
felix
otero
carrasco
principl
translat
inhibitor
target
compon
protein
synthes
machineri
would
block
viral
cellular
translat
nonspecif
action
compound
puromycin
levintow
et
al
pactamycin
summer
maizel
taber
et
al
use
studi
depend
viral
rna
synthesi
viral
translat
levintow
et
al
map
viral
protein
picornaviru
genom
lawson
semler
howev
select
inhibit
compar
blockad
host
protein
synthesi
uninfect
cell
select
way
block
protein
synthesi
anim
virusinfect
cell
devis
base
modif
membran
permeabl
viru
infect
approach
employ
use
hydrophil
translat
inhibitor
easili
cross
membran
barrier
normal
uninfect
cell
readili
enter
number
anim
virusinfect
cell
carrasco
contrera
carrasco
vizquez
carrasco
et
al
studi
show
bulk
picornaviru
protein
synthesi
occur
cell
membran
drastic
modifi
presenc
translat
inhibitor
block
select
synthesi
viral
protein
also
block
format
new
infecti
viru
indic
viru
assembl
take
place
larg
membran
modifi
benedetto
et
al
henc
inhibitor
translat
hydrophil
inhibit
protein
synthesi
effici
intact
cell
abl
select
block
translat
varieti
anim
virusinfect
cell
carrasco
use
test
measur
chang
membran
permeabl
cell
infect
anim
virus
also
cell
type
eukaryot
prokaryot
membran
permeabl
alter
carrasco
b
otero
carrasco
lama
carrasco
format
infecti
viru
agent
strongli
diminish
drug
concentr
affect
translat
uninfect
cell
benedetto
et
al
lacal
et
al
lacai
carrasco
therefor
cell
kill
low
multipl
polioviru
prevent
treatment
cell
monolay
hygromycin
b
lacal
carrasco
select
achiev
inhibitor
translat
enter
equal
well
virusinfect
uninfect
cell
contrera
carrasco
lacal
carrasco
approach
exploit
anim
nonperm
antibiot
block
translat
potent
occur
guanylyl
methylen
diphosph
dawson
et
al
show
toxic
unpublish
result
perhap
due
differ
cellular
suscept
anim
prolong
treatment
howev
approach
use
inhibitor
viral
cellular
function
select
enter
virusinfect
cell
earli
late
infect
result
modif
membran
permeabl
remain
open
word
select
confer
antivir
compound
ad
charg
residu
make
less
permeabl
uninfect
cell
wherea
charg
molecul
readili
enter
virusinfect
cell
fact
observ
highli
charg
compound
sulphat
polysaccharid
suramin
dye
trypan
blue
show
good
antivir
activ
et
al
entri
sulphat
polysaccharid
cell
enhanc
polioviru
particl
gonzfilez
carrasco
see
section
agent
use
number
laboratori
test
antivir
effect
sever
anim
virus
includ
human
immunodefici
viru
hiv
mitsuya
et
al
mitsuya
et
al
balzarini
et
al
gonzfilez
et
al
zuckerman
schol
et
al
callahan
et
al
mcclure
et
al
viral
genom
liber
cytoplasm
polioviru
entri
recogn
ribosom
translat
machineri
mrna
sonenberg
translat
input
viral
rna
give
rise
number
virusencod
protein
necessari
replic
genom
semler
et
al
richard
ehrenfeld
although
mani
detail
step
involv
replic
polioviru
rna
unravel
perhap
one
least
understood
process
molecular
term
particularli
initi
new
rna
chain
possibl
role
play
cellular
protein
requir
membran
genom
replic
semler
et
al
richard
ehrenfeld
replic
rna
involv
rna
dna
intermedi
occur
retrovirus
hepadnavirus
perhap
one
primit
process
multipl
biolog
molecul
understand
picornavirus
accomplish
replic
shed
light
essenti
requir
one
primit
form
life
elucid
complex
rnacontain
virus
abl
replic
genom
infect
cell
addit
requir
replic
rna
genom
defin
use
amplif
kind
rna
molecul
either
intact
cell
cellfre
system
alreadi
achiev
phage
rna
wu
et
al
one
essenti
step
requir
amplif
positivestrand
rna
molecul
copi
rna
complementari
chain
turn
use
templat
synthesi
positivestrand
rna
molecul
semler
et
al
richard
ehrenfeld
fig
thu
picornavirusinfect
cell
two
class
rna
molecul
present
genom
positivestrand
rna
exact
copi
rna
negativestrand
rna
semler
et
al
richard
ehrenfeld
approxim
time
rna
rna
molecul
infect
cell
relat
vari
depend
upon
cell
line
infect
baltimor
baltimor
girard
hewlett
et
al
singlestrand
rna
found
cell
posit
polar
encapsid
virion
serv
mrna
synthesi
viral
protein
encapsid
form
virion
rna
coval
bound
protein
vpg
molecul
wu
et
al
ri
found
cell
consist
complet
rna
molecul
use
templat
make
copi
rna
present
nascent
rna
molecul
nascent
rna
chain
per
ri
contain
vpg
molecul
bound
fact
molecul
present
form
rna
posit
neg
form
part
ri
rf
well
establish
enzym
requir
elong
rna
flanegan
van
dyke
enzym
howev
unabl
initi
synthesi
new
rna
chain
semler
et
al
richard
ehrenfeld
polymeras
abl
copi
rna
use
primer
anoth
rna
molecul
templat
richard
ehrenfeld
fact
first
enzym
kind
found
mammalian
cell
describ
baltimor
et
al
picornavirusinfect
cell
apart
total
number
protein
requir
replic
picornaviru
genom
yet
establish
virusencod
protein
necessari
cellular
protein
may
also
involv
semler
et
al
richard
ehrenfeld
addit
viral
cellular
protein
need
synthes
continu
particip
synthesi
viral
rna
inhibit
protein
synthesi
picornavirusinfect
cell
lead
almost
immedi
arrest
viral
rna
synthesi
fig
viral
protein
implic
replic
polioviru
genom
certainli
particip
elong
process
vpg
also
necessari
semler
et
al
richard
ehrenfeld
remain
unclear
vpg
act
primer
initi
synthesi
new
rna
chain
vpg
ad
later
initi
accomplish
takegami
et
al
tobin
et
al
two
altern
possibl
illustr
fig
accord
model
vpg
either
precursor
presenc
utp
still
unidentifi
protein
uridyl
vpgump
elong
vpgpupup
takeda
et
al
substrat
use
primer
elong
rna
chain
takeda
et
al
rna
start
pupup
possibl
vpg
alon
particip
format
process
precursor
molecul
thu
would
serv
anchor
membran
way
would
hang
membran
readi
uridyl
takegami
et
al
wimmer
et
al
synthes
elong
process
commenc
hydrolyz
releas
membran
would
remain
imbed
lipid
bilay
indic
firm
candid
modifi
membran
permeabl
lyse
infect
cell
lama
carrasco
carrasco
et
al
model
b
fig
vpg
particip
real
initi
event
sinc
yoh
group
present
hairpin
use
directli
elong
rna
chain
vpg
bind
somewher
elong
reaction
catalyz
requir
nucleotid
hydrolysi
tobin
et
al
thu
far
model
confirm
laboratori
apart
role
vpg
indirectli
play
genom
replic
viral
protein
also
implic
process
although
function
obscur
semler
et
al
richard
ehrenfeld
genet
studi
indic
function
perhap
also
necessari
replic
viral
rna
sarnow
et
al
kirkegaard
compel
evid
implic
rna
synthesi
came
studi
viral
inhibitor
guanidin
caliguiri
tamm
compound
select
inhibitor
rna
synthesi
picornavirus
see
section
eleg
studi
prove
act
polioviru
protein
addit
polioviru
mutat
replic
viral
rna
li
baltimor
mutant
also
defect
virion
assembl
suggest
may
also
involv
late
viral
step
li
baltimor
sequenc
analysi
suggest
could
gtpase
possess
glyrich
region
follow
sequenc
gk
sequenc
present
gtpase
inde
vitro
studi
purifi
protein
indic
gtpase
activ
rodriguez
carrasco
homolog
picornaviru
potyviru
protein
ci
lain
et
al
suggest
gorbalenya
et
al
basi
claim
belong
rnahelicas
superfamili
howev
helicas
activ
yet
demonstr
isol
rodriguez
carrasco
although
activ
present
cho
et
al
fact
suggest
may
repres
new
class
small
gtpbind
protein
role
could
direct
traffick
rna
replic
complex
vesicular
system
rodriguez
carrasco
clearli
experi
need
clarifi
activ
replic
polioviru
genom
protein
either
precursor
also
requir
replic
picornaviru
genom
johnson
sarnow
polioviru
mutat
impair
abil
synthes
viral
rna
clue
exact
role
protein
process
sarnow
et
al
kirkegaard
mutat
protein
complement
tran
suggest
actual
protein
made
particular
rna
function
replic
rna
johnson
sarnow
inde
phenomenon
much
complic
possibl
use
picornaviru
system
model
replic
kind
rna
cell
cellfre
system
kirkegaard
final
may
also
particip
rna
replic
apart
cleav
nascent
polypeptid
chain
synthes
krausslich
must
anoth
role
viral
growth
idea
strongli
support
fact
polioviru
monster
recent
construct
contain
region
separ
emc
untransl
region
requir
presenc
even
though
protein
initi
intern
aug
molla
et
al
major
evid
hostfactor
requir
replic
picornaviru
genom
come
cellfre
system
semler
et
al
richard
ehrenfeld
system
extrem
use
clarifi
process
molecular
detail
also
prone
artifact
thu
kda
protein
uridyl
activ
isol
infect
cell
replac
oligo
u
primer
initi
new
polioviru
rna
chain
dasgupta
et
al
baron
baltimor
dasgupta
host
factor
identifi
protein
kinas
phosphoryl
morrow
et
al
role
activ
may
poliovirusrna
replic
elucid
semler
et
al
richard
ehrenfeld
requir
host
factor
picornaviru
rna
replic
also
requir
investig
replic
polioviru
genom
take
place
close
associ
newli
made
membran
vesicl
semler
et
al
richard
ehrenfeld
polioviru
infect
synthesi
membran
profoundli
modifi
cytoplasm
load
vesicl
variou
size
form
distinct
perinuclear
structur
dale
et
al
caliguiri
tamm
b
mosser
et
al
distinct
structur
term
viroplasm
dale
et
al
synthesi
phospholipid
increas
polioviru
infect
provid
compon
membran
gener
mosser
et
al
polioviru
replic
complex
tightli
associ
newli
made
membran
girard
baltimor
tamm
bienz
et
al
bienz
et
al
troxler
et
al
although
littl
known
origin
membran
vesicl
appear
poliovirusinfect
cell
connect
vesicl
membran
compart
vitro
synthesi
polioviru
minusor
plusstrand
rna
achiev
use
crude
membran
replic
complex
girard
etchison
ehrenfeld
takeda
et
al
prevent
lipid
synthesi
result
abrupt
inhibit
viral
rna
synthesi
carrasco
suggest
replic
viral
genom
requir
continu
membran
format
see
section
elucid
mechan
use
polioviru
replic
genom
interest
number
reason
exampl
understand
step
protein
involv
process
shed
light
relationship
viru
host
cell
koch
koch
wimmer
et
al
semler
et
al
richard
ehrenfeld
complet
synthesi
polioviru
cellfre
system
alreadi
achiev
molla
et
al
barton
flanegan
system
help
clarifi
step
compon
involv
polioviru
rna
replic
addit
interplay
knowledg
gain
polioviru
rna
synthesi
inhibitor
process
sinc
detail
understand
step
follow
polioviru
anim
virus
replic
genom
import
exploit
new
approach
interfer
replic
pathogen
moreov
better
understand
mode
action
inhibitor
polioviru
rna
replic
may
help
elucid
process
guanidin
fig
basic
compound
posit
charg
neutral
ph
natur
constitu
anim
serum
activ
member
picornavirida
togavirida
famili
friedman
mani
way
model
inhibitor
polioviru
despit
fact
one
least
potent
agent
viral
rna
synthesi
mm
tershak
tershak
sever
guanidin
deriv
nevertheless
synthes
potent
antivir
activ
bucknal
et
al
soon
discoveri
guanidin
antivir
agent
rightsel
et
al
polioviru
mutant
resist
depend
guanidin
describ
loddo
et
al
nakano
et
al
picornavirus
inhibit
guanidin
polioviru
rhinoviru
fmdv
wherea
emc
viru
resist
compound
caliguiri
tamm
tershak
et
al
guanidin
advers
effect
cell
growth
concentr
block
viru
growth
direct
effect
isol
virion
viru
attach
inhibitor
ad
hr
infect
block
translat
wherea
incorpor
uridin
polioviru
rna
suppress
compound
ad
viru
entri
synthesi
viral
protein
rna
prevent
caliguiri
tamm
tershak
et
al
moreov
low
moder
multipl
infect
guanidin
larg
prevent
shutoff
host
protein
synthesi
induc
polioviru
wherea
high
multipl
infect
kinet
earli
shutoff
similar
absenc
presenc
inhibitori
concentr
guanidin
lacal
carrasco
detail
initi
studi
guanidin
reader
refer
comprehens
review
caliguiri
tamm
tershak
et
al
earli
studi
mode
action
guanidin
indic
compound
block
initi
new
round
viral
rna
synthesi
allow
complet
alreadi
initi
rna
strand
tamm
b
tershak
et
al
known
certainti
whether
guanidin
select
inhibitor
synthesi
plusstrand
rna
block
equal
well
synthesi
plusor
minusstrand
rna
indecis
due
fact
difficult
block
synthesi
one
strand
rna
without
affect
care
kinet
analys
use
variou
concentr
guanidin
ad
differ
time
infect
knowledg
carri
recent
complet
synthesi
infecti
polioviru
accomplish
cellfre
system
system
polioviru
genom
rna
ad
hela
cell
extract
sever
hour
incub
infecti
polioviru
particl
made
molla
et
ai
guanidin
block
format
particl
indic
least
condit
synthesi
plusstrand
rna
initi
rna
take
place
vitro
molla
et
al
inhibit
guanidin
ofpolioviru
fmdv
revers
sever
amino
acid
methionin
valin
leucin
threonin
dinter
bengston
lwoff
agent
includ
methylpropanolamin
ethanolamin
cholin
philipson
et
al
revers
much
depend
host
cell
type
analyz
transport
guanidin
hela
cell
involv
least
two
possibl
mechan
nair
regul
concentr
cation
medium
nair
antiguanidin
agent
block
transport
may
constitut
basi
antiguanidin
action
rather
could
antagon
guanidin
intracellularli
unknown
mechan
nair
indic
earlier
section
feasibl
gener
mutant
allow
genet
map
provid
inform
viral
protein
target
guanidin
action
anderson
sillman
et
al
pincu
et
al
initi
studi
suggest
capsid
protein
proteas
even
vpg
target
guanidin
detail
analys
guanidineresist
guanidinedepend
mutant
polioviru
indic
map
protein
baltera
tershak
similar
conclus
reach
fmdv
guanidin
mutant
saunder
king
analys
polypeptid
fmdv
polioviru
guanidineresist
mutant
suggest
protein
respons
trait
transfect
co
cell
plasmid
contain
edna
fragment
correspond
polioviru
protein
guanidineresist
guanidinedepend
mutant
plasmid
contain
infecti
clone
wildtyp
polioviru
gave
rise
type
mutant
viru
sequenc
analys
indic
mutat
amino
acid
residu
protein
confer
resist
high
guanidin
concentr
wherea
chang
residu
combin
mutat
posit
gener
guanidinedepend
modif
residu
polioviru
protein
combin
mutat
residu
could
also
confer
guanidin
resist
baltera
tershak
final
frequenc
revers
guanidinedepend
mutant
polioviru
resist
phenotyp
establish
mutat
frequenc
x
number
consist
genet
variabl
rnacontain
virus
domingo
domingo
holland
et
al
drake
updat
view
mode
action
guanidin
could
follow
guanidin
act
protein
perhap
inhibit
interact
protein
membran
protein
gtpase
may
involv
traffick
viral
rna
replic
complex
vesicular
system
rodriguez
carrasco
traffic
necessari
polioviru
emc
viru
genom
replic
irurzun
et
al
thu
guanidin
block
activ
traffic
replic
complex
henc
initi
viral
rna
synthesi
mode
action
may
also
explain
guanidin
affect
step
assembl
new
virion
also
take
place
close
associ
newlyform
membran
vesicl
koch
koch
guanidin
deriv
use
sever
pharmacolog
studi
davidoff
compound
provok
enhanc
nerv
excit
inject
frog
may
play
role
pathogenesi
urem
poison
although
serum
level
guanidin
similar
control
urem
patient
excret
methylguanidin
higher
patient
renal
failur
stein
micklu
find
togeth
fact
high
concentr
mm
guanidin
requir
effici
blockag
polioviru
vitro
indic
guanidin
use
therapeut
guanidin
ineffect
treatment
polioviru
infect
anim
rapid
secret
compound
rapid
develop
guanidineresist
virus
anim
caliguiri
tamm
fact
administr
guanidin
alon
mice
infect
echoviru
coxsacki
viru
protect
partial
respons
observ
combin
thydroxybenzyl
benzimidazol
hbb
guanidin
indic
sever
day
delay
death
egger
thiosemicarbazon
fig
use
therapeut
agent
treatment
tuberculosi
antivir
agent
sever
anim
virus
levinson
pfau
isatinflthiosemicarbazon
inhibit
vaccinia
viru
rhinovirus
katz
feliz
pennington
effect
polioviru
pearson
zimmerman
activ
methisazon
nmethylisatinflthiosemicarbazon
sever
picornavirus
report
bauer
et
al
variou
speci
virus
includ
polioviru
directli
inactiv
upon
contact
methisazon
presenc
fox
et
al
busatin
block
polioviru
osullivan
sadler
pearson
zimmerman
interf
synthesi
viral
rna
ad
time
infect
pearson
zimmerman
contrast
action
hbb
see
section
guanidin
busatin
block
polioviru
rna
synthesi
cellfre
system
pearson
zimmerman
respect
show
similar
gliotoxin
rodriguez
carrasco
deriv
thiosemicarbazon
triazinoindol
skf
skf
skf
skf
fig
broadspectrum
antipicornaviru
agent
block
sever
rhinoviru
strain
matsumoto
et
al
pfau
skf
antirhinoviru
activ
administ
intranas
gibbon
use
oral
pinto
et
al
skf
skf
effect
rhinoviru
infect
human
togo
et
ai
sever
benzimidazol
deriv
fig
show
activ
number
anim
virus
caliguiri
tamm
tamm
sehgal
egger
egger
exampl
hbb
select
inhibitor
picornaviru
replic
inactiv
virion
particl
block
replic
viral
rna
without
affect
synthesi
cellular
rna
egger
tamm
singh
et
al
structureact
relationship
hbb
deriv
fairli
well
document
caliguiri
tamm
tamm
sehgal
egger
egger
show
benzo
group
hydroxybenzyl
residu
posit
critic
activ
hbb
deriv
report
activ
hbb
caliguiri
tamm
tamm
sehgal
egger
egger
hbb
broadspectrum
antipicornaviru
agent
activ
polioviru
coxsacki
virus
devoid
activ
rhinovirus
fmdv
hepat
viru
siegl
egger
concentr
hbb
requir
activ
polioviru
similar
guanidin
wherea
hbb
potent
guanidin
coxsacki
viru
action
hbb
polioviru
found
guanidin
flavon
revers
upon
withdraw
compound
viru
growth
resum
caliguiri
tamm
tamm
sehgal
egger
egger
studi
mode
action
hbb
indic
effect
earli
step
infect
viru
entri
uncoat
egger
tamm
addit
compound
polioviru
entri
prevent
appear
viral
protein
viral
rna
replic
block
thu
incorpor
label
uridin
viral
rna
format
poliovirusspecif
rna
analyz
dotblot
hybrid
inhibit
hbb
egger
tamm
gonztlez
et
al
compound
effect
vitro
synthesi
viral
rna
still
known
initi
elong
step
select
block
agent
vivo
number
picornaviru
mutant
resist
depend
hbb
isol
crossresist
guanidin
egger
tamm
depend
mutant
requir
hbb
replic
viral
rna
hbb
replac
guanidin
respect
egger
tamm
mutant
hbbdepend
virus
backmut
sensit
phenotyp
high
frequenc
caliguiri
tamm
figur
similar
mutat
rate
picornavirus
trait
investig
de
la
torr
et
al
domingo
hbb
guanidin
act
synergist
singh
et
al
suggest
exact
target
inhibit
compound
differ
although
could
act
viral
protein
investig
antivir
effect
hbb
mice
monkey
carri
caliguiri
tamm
egger
although
earli
experi
yield
margin
effect
hbb
virusinfect
anim
newborn
mice
inocul
echoviru
coxsacki
viru
protect
combin
treatment
hbb
guanidin
egger
hbb
alon
protect
coxsacki
virusinfect
anim
infect
echoviru
egger
enviroxim
isopropylsulfonyl
phenyl
keton
oxim
fig
benzimidazol
deriv
high
activ
rhinovirus
delong
reed
sever
human
trial
use
enviroxim
prophylact
agent
common
cold
produc
rhinovirus
report
hayden
gwaltney
levandowski
et
al
phillpot
et
al
clear
benefit
observ
levandowski
et
al
although
incorpor
enviroxim
liposom
result
improv
drug
deliveri
lung
mice
wyde
et
al
studi
mode
action
drug
retard
compound
freeli
avail
eli
lilli
research
laboratori
research
studi
flavonoid
ubiquit
compound
plant
kingdom
harborn
search
antivir
agent
plant
extract
led
discoveri
quercetin
african
medicin
plant
euphorbia
grantii
van
hoof
et
al
vlietinck
et
al
ro
fig
chines
medicin
herb
agastach
rugosa
ishitsuka
et
al
analysi
mode
action
indic
select
inhibitor
polioviru
rna
synthesi
concentr
gme
inhibit
uridin
incorpor
poliovirusinfect
cell
wherea
effect
cellular
transcript
castrillo
et
al
analysi
viral
rna
synthes
presenc
flavon
show
product
singlestrand
rna
total
block
wherea
synthesi
dsrna
still
detect
castrillo
carrasco
thu
behav
like
ro
block
synthesi
plusand
minusrna
ad
incept
infect
enough
genom
rna
serv
templat
give
rise
signific
amount
negativestrand
rna
detect
hybrid
lopez
pila
et
al
gonzdez
et
al
therefor
order
test
flavon
select
must
ad
later
infect
suffici
amount
plusand
minusstrand
rna
made
addit
ro
late
infect
affect
viral
rna
synthesi
way
suggest
preferenti
inhibit
polioviru
genom
rna
gonzfilez
et
al
howev
detail
understand
molecular
mode
action
ro
still
lack
know
yet
viral
protein
target
also
known
initi
elong
step
viral
rna
synthesi
block
compound
moreov
recent
found
flavon
may
block
earli
step
polioviru
growth
suggest
flavon
could
directli
interact
viral
particl
block
uncoat
irurzun
l
carrasco
unpublish
result
ro
inhibit
polioviru
replic
concentr
lower
shown
hbb
guanidin
respect
gonzfilez
et
al
ro
select
block
viral
rna
synthesi
poliovirusinfect
hela
cell
strongli
find
make
ro
valuabl
compound
obtain
insight
molecular
mechan
polioviru
rna
replic
quercetin
morin
effect
mengovirusinduc
enceph
mice
given
oral
veckenstedt
et
al
two
flavonoid
show
select
inhibit
polioviru
cultur
cell
castrillo
et
al
gonzdez
et
al
diacyl
deriv
ro
absorb
better
parent
compound
intestin
tract
make
effect
lethal
coxsacki
infect
mice
ishitsuka
et
al
gliotoxin
fig
fungal
metabolit
produc
variou
speci
trichoderma
aspergillu
penicillium
possess
differ
biolog
activ
includ
antivir
effect
suhadolnik
miller
et
al
mcdougal
gliotoxin
number
relat
compound
deriv
either
natur
sourc
chemic
synthesi
potent
agent
interfer
polioviru
rna
synthesi
miller
et
al
trown
bilello
presenc
reduc
agent
dithiothreitol
prevent
inhibit
polioviru
rna
synthesi
intact
cell
trown
bilello
suggest
blockad
gliotoxin
involv
format
disulfid
bridg
gliotoxin
essenti
sulfhydryl
group
viral
polymeras
presenc
dithiothreitol
cellfre
system
partial
lower
gliotoxin
inhibitori
potenti
agreement
idea
reduc
sulfhydryl
group
abolish
activ
gliotoxin
trown
bilello
rodriguez
carrasco
mode
action
gliotoxin
polioviru
analyz
detail
rodriguez
carrasco
fungal
metabolit
irrevers
inhibit
appear
polioviru
protein
present
begin
infect
effect
viral
translat
ad
later
toxin
potent
inhibit
incorpor
uridin
polioviru
rna
soon
addit
cultur
medium
miller
et
al
rodriguez
carrasco
analysi
synthesi
polioviru
plusor
minusstrand
rna
presenc
gliotoxin
indic
compound
effect
hamper
process
rodriguez
carrasco
result
contrast
mode
action
inhibitor
polioviru
rna
synthesi
flavon
select
block
plusstrand
rna
synthesi
suggest
target
gliotoxin
may
differ
target
flavon
gliotoxin
potent
inhibitor
ofpolioviru
rna
synthesi
cellfre
system
use
membran
crude
replic
complex
reaction
block
guanidin
hbb
ro
moreov
vitro
assay
use
purifi
polioviru
polymeras
effici
inhibit
gliotoxin
first
descript
inhibitor
viral
enzym
rodriguez
carrasco
gliotoxin
rather
toxic
anim
mice
mgml
intraven
mgml
intraperiton
larin
et
al
despit
toxic
gliotoxin
exert
antivir
effect
monkey
inocul
larg
dose
polioviru
larin
et
al
antipicornaviru
activ
also
describ
compound
relat
gliotoxin
includ
aranotin
acetylaranotin
apoaranotin
fig
isol
cultur
medium
fungi
arachniotu
aureu
aspergillu
terreu
trown
sirodesmin
fig
isol
fungu
sirodesmium
dioersum
sirodesmin
b
c
differ
number
sulfur
atom
bridg
two
three
four
respect
sever
hyalodendrin
fig
also
differ
number
sulfur
atom
bridg
isol
fungi
hyalodendrin
speci
penicillium
turbatum
michel
et
al
compound
inhibit
polioviru
rhinoviru
coxsacki
viru
multipl
trown
michel
et
al
synthet
compound
n
ndimethylepidithiapiperazinedion
fig
also
potent
inhibitor
coxsacki
viru
rna
synthesi
trown
natur
compound
aldgamycin
e
fig
macrolid
antibiot
produc
streptomyc
lavandula
inhibit
growth
polioviru
anim
virus
test
gonzlez
carrasco
unpublish
result
blockad
viral
translat
take
place
antibiot
present
incept
infect
effect
polioviru
protein
synthesi
observ
agent
ad
later
suggest
protein
synthesi
primari
target
antibiot
action
inde
polioviru
rna
synthesi
profoundli
depress
soon
addit
aldgamycin
e
macrolid
antibiot
chalcomycin
josamycin
venturicidin
also
block
polioviru
rna
synthesi
indic
macrolid
antibiot
constitut
promis
sourc
new
antivir
agent
gonzdez
carrasco
unpublish
result
dipyridamol
fig
synthet
compound
coronari
vasodil
dipyridamol
sever
deriv
activ
certain
dna
rna
virus
cell
cultur
includ
mengoviru
kuwata
et
al
tonew
et
al
synthesi
mengoviru
rna
complet
block
dipyridamol
condit
transport
uridin
affect
ie
precharg
cell
label
uridin
kuwata
et
al
tonew
et
al
detail
analys
use
hybrid
specif
probe
necessari
dipyridamol
also
affect
nucleosid
transport
indic
section
action
guanidin
antagon
number
amino
acid
basi
suggest
certain
analogu
amino
acid
might
also
show
antipolioviru
activ
dpenicillamin
fig
valin
analogu
inhibit
polioviru
growth
revers
block
synthesi
polioviru
rna
drug
concentr
mgml
rel
concentr
singlestrand
doublestrand
polioviru
rna
vari
presenc
compound
certainli
dpenicillamin
potent
polioviru
inhibitor
drug
concentr
ram
total
blockad
viral
dna
synthesi
achiev
merryman
et
al
inhibitori
effect
dpenicillamin
revers
antagon
sever
amino
acid
one
potent
inhibitor
lipid
biosynthesi
prokaryot
eukaryot
cell
cerulenin
fig
antibiot
produc
cephalosporium
caerulen
bachrach
et
al
block
fattyacid
synthetas
level
flketoacyl
thioester
synthetas
condens
enzym
armstrong
et
al
butterworth
rueckert
bachrach
et
al
present
initi
polioviru
infect
potent
inhibit
polioviru
protein
synthesi
effect
viral
translat
proteolyt
process
viral
protein
ad
late
guinea
carrasco
myristoyl
viral
protein
precursor
block
cerulenin
cerulenin
inhibit
quickli
replic
polioviru
rna
ad
time
infect
guinea
carrasco
wherea
effect
cellular
transcript
antibiot
depress
incorpor
label
glycerol
phospholipid
inhibit
parallel
blockad
viral
rna
replic
synthesi
polioviru
plusstrand
rna
synthesi
hamper
guinea
carrasco
cerulenin
direct
inhibitori
effect
polioviru
translat
indic
synthesi
phospholipid
continu
requir
synthesi
plusstrand
polioviru
rna
henc
link
membran
traffic
polioviru
rna
replic
antibiot
also
inhibitor
envelop
rnacontain
virus
schlesing
malfer
ikuta
luftig
pal
et
al
thu
replic
retrovirus
includ
hiv
type
block
cerulenin
pal
et
al
propos
process
structur
protein
acyl
glycoprotein
could
target
cerulenin
inhibit
viral
growth
schlesing
malfer
ikuta
luftig
pal
et
al
inhibit
phospholipid
synthesi
cerulenin
also
impair
synthesi
nucleic
acid
virus
emc
viru
sfv
vsv
guinea
carrasco
fact
synthesi
nucleic
acid
togavirus
mani
anim
virus
close
connect
synthesi
new
membran
structur
synthesi
membran
structur
requir
de
novo
synthesi
phospholipid
seem
plausibl
inhibit
lipid
synthesi
would
certainli
lead
inhibit
viral
nucleic
acid
synthesi
compound
block
phospholipid
synthesi
includ
tofa
hydroxyacet
acid
fig
act
similar
manner
cerulenin
guinea
carrasco
unpublish
result
clofibr
compound
potenti
oxid
fatti
acid
penteno
acid
inhibitor
fatti
acid
oxid
hemicholinium
inhibitor
cholin
incorpor
phosphatidylcholin
compactin
inhibitor
cholesterol
synthesi
effect
polioviru
hand
agar
acid
inhibitor
fatti
acid
synthesi
sodium
palmoxir
anoth
agent
block
fatti
acid
oxid
toxic
control
cell
allow
assay
effect
poliovirusinfect
cell
guinea
carrasco
unpublish
result
tofa
hydroxycitr
two
known
inhibitor
lipid
synthesi
block
appear
polioviru
protein
present
earli
stage
infect
analys
effect
two
compound
polioviru
replic
indic
action
polioviru
protein
synthesi
ad
late
infect
wherea
potent
depress
polioviru
rna
synthesi
guinea
carrasco
unpublish
result
furthermor
compound
also
inhibitori
effect
phospholipid
synthesi
poliovirusinfect
cell
result
indic
agent
interfer
phospholipid
biosynthesi
cerulenin
tofa
hydroxycitr
hamper
replic
polioviru
rna
thu
mode
action
agent
differ
wellknown
polioviru
rna
inhibitor
guanidin
guanidin
effect
lipid
synthesi
membran
continu
motion
sever
compart
eukaryot
cell
ovtracht
rotbman
orci
lippincottschwartz
brefeldin
bfa
fig
fungal
antibiot
isol
penicillium
brefeldianum
antivir
properti
block
protein
secret
vesicular
traffic
hunzik
et
al
klausner
et
al
induc
rapid
disaggreg
golgi
complex
caus
redistribut
endoplasm
reticulum
lippincottschwartz
et
al
alcald
et
al
within
second
bfa
treatment
peripher
protein
kda
golgi
apparatu
releas
cytoplasm
golgi
membran
enzym
catalyz
exchang
guanin
nucleotid
onto
arf
inhibit
helm
rothman
sinc
transport
protein
postgolgi
compart
cell
potent
block
bfa
deliveri
vsv
g
glycoprotein
plasma
membran
misumi
et
al
fujiwara
et
al
dom
et
al
oda
et
al
addit
vsv
increas
number
anim
virus
report
affect
inhibitor
ulmer
palad
chen
et
al
cheung
et
al
wheali
et
al
bfa
inhibit
process
transport
glycoprotein
present
virus
manner
envelop
virus
matur
plasma
membran
matur
intracellularli
inhibit
macrolid
antibiot
ulmer
palad
chen
et
al
cheung
et
al
wheali
et
al
bfa
strongli
inhibit
polioviru
replic
irurzun
et
al
maynel
et
al
even
though
viru
lack
lipid
envelop
encod
glycoprotein
urzainqui
carrasco
addit
bfa
begin
polioviru
infect
block
synthesi
late
protein
effect
cleavag
indic
input
viral
rna
translat
produc
activ
irurzun
et
al
presenc
bfa
later
time
effect
polioviru
protein
synthesi
step
direct
target
antibiot
inde
target
bfa
viral
rna
synthesi
addit
antibiot
time
polioviru
infect
drastic
reduc
incorpor
label
uridin
polioviru
rna
irurzun
et
al
maynel
et
al
plusand
minusstrand
rna
synthesi
diminish
bfa
present
begin
infect
plusstrand
rna
synthesi
affect
inhibitor
ad
later
time
irurzun
et
al
effect
bfa
late
protein
synthesi
anim
virus
vari
accord
viru
speci
irurzun
et
al
among
picornavirus
rhinovirus
sensit
antibiot
wherea
emc
viru
resist
negativestrand
rna
viru
vesicular
stomat
block
bfa
wherea
vaccinia
viru
cytoplasm
dna
viru
resist
irurzun
et
al
follow
even
virus
contain
lipid
envelop
synthes
glycoprotein
may
requir
newli
made
membran
allow
synthesi
new
genom
irurzun
et
al
maynel
et
al
polioviru
protein
synthes
bind
membran
rough
endoplasm
reticulum
migrat
golgi
complex
follow
rout
use
glycoprotein
fig
polioviru
protein
reach
transgolgi
network
assign
special
structur
form
membran
vesicl
rna
replic
complex
see
section
find
bfa
immedi
block
polioviru
rna
synthesi
without
affect
translat
suggest
rna
synthesi
take
place
associ
newli
made
vesicl
preexist
vesicl
support
format
new
genom
find
help
clarifi
action
number
antivir
agent
interfer
replic
genom
without
affect
viral
polymeras
addit
exploit
devis
select
antivir
agent
least
theoret
could
interfer
action
viral
protein
involv
coupl
membran
vesicl
rna
replic
complex
addit
fatti
acid
cell
cultur
increas
lipid
synthesi
cowen
heydrick
burkhardt
convers
unsatur
fatti
acid
oleic
acid
increas
membran
fluiditi
diminish
infect
hemolyt
activ
envelop
anim
viru
particl
effect
describ
nonlipidenvelop
anim
viru
particl
kohn
et
al
sola
et
al
oleic
acid
fig
block
synthesi
polioviru
protein
concentr
affect
translat
uninfect
cell
inhibit
due
blockad
viral
rna
synthesi
probabl
consequ
modif
membran
connect
rna
replic
complex
addit
oleic
acid
fatti
acid
begin
polioviru
infect
specif
inhibit
appear
viru
polypeptid
concentr
affect
translat
mockinfect
hela
cell
inhibit
probabl
due
blockad
viral
rna
synthesi
oleic
acid
interfer
synthesi
polioviru
rna
vivo
cellfre
system
oleic
acid
increas
synthesi
phosphatidylcholin
neutral
lipid
membran
made
poliovirusinfect
cell
presenc
oleic
acid
differ
buoyant
densiti
control
membran
incorpor
oleic
acid
membran
lead
increas
membran
fluiditi
decreas
buoyant
densiti
make
membran
nonfunct
rna
replic
therefor
synthesi
phospholipid
requir
viral
rna
synthesi
guinea
carrasco
proper
structur
newli
made
membran
also
import
permit
replic
polioviru
genom
interferon
cellular
protein
synthes
respons
sever
induc
stringfellow
sehgal
et
al
possess
antivir
activ
de
maeyer
et
al
staeh
kerr
stark
interact
interferon
molecul
appropri
receptor
cell
surfac
induc
synthesi
number
protein
thu
establish
antivir
state
kerr
stark
mcnair
kerr
precis
action
protein
replic
anim
virus
remain
larg
unknown
taylor
grossberg
case
picornavirus
well
establish
treatment
suscept
cell
differ
interferon
speci
profoundli
block
viral
growth
see
review
mufioz
carrasco
treatment
cell
human
interferon
follow
subsequ
infect
polioviru
prevent
inhibit
host
protein
synthesi
indic
translat
input
viral
rna
take
place
mufioz
carrasco
isol
rna
poliovirusinfect
cell
treat
interferon
indic
ribosom
rna
remain
intact
cellular
mrna
translat
degrad
cellular
rna
basi
interferon
action
mufioz
et
al
precis
step
inhibit
picornaviru
growth
cell
treat
interferon
remain
larg
unexplor
despit
larg
number
public
investig
effect
cellfre
system
good
knowledg
particular
enzym
induc
interferon
cell
mufioz
carrasco
quit
probabl
synthesi
picornavir
rna
step
block
interferontr
cell
mufioz
carrasco
mufioz
et
al
assum
mani
group
interferon
primarili
block
viral
translat
effect
mediat
ppp
na
synthetas
andor
protein
kinas
upon
activ
dsrna
taylor
grossberg
kerr
stark
zhou
et
al
difficult
establish
whether
interferon
primarili
block
transcript
translat
picornavirus
also
rna
virus
interfer
viral
rna
synthesi
usual
lead
reduct
viral
protein
synthesi
vice
versa
nevertheless
case
polioviru
translat
input
rna
impair
interferontr
cell
mufioz
carrasco
moreov
human
cell
treat
interferon
doublyinfect
polioviru
reoviru
synthes
reoviru
protein
even
though
polioviru
replic
impair
mufioz
et
al
mufioz
carrasco
find
indic
indiscrimin
inhibit
viral
protein
interferont
cell
infect
polioviru
cell
make
reoviru
protein
control
level
even
though
antivir
state
polioviru
exist
cell
mechan
underli
blockad
picornavirus
interferon
also
unclear
interferon
block
viral
rna
synthesi
accomplish
possibl
interferon
block
translat
emc
viru
mengoviru
activ
synthetas
andor
protein
kinas
investig
verhaegenlewal
et
al
rice
et
al
kumar
et
al
lewi
variou
report
show
correl
activ
enzym
establish
antivir
state
picornavirusinfect
cell
verhaegenlewau
et
al
kumar
et
al
lewi
also
viral
system
mufioz
carrasco
taylor
grossberg
even
case
reovirus
contain
dsrna
genom
inhibit
viral
protein
synthesi
hela
cell
even
though
synthetas
protein
kinas
induc
feduchi
et
al
transfect
synthetas
protein
kinas
inhibit
viru
growth
chebath
et
al
coccia
et
al
meur
et
al
lee
esteban
remain
determin
inhibit
relat
mode
action
interferon
cell
transfect
synthetas
gene
support
growth
vsv
chebath
et
al
coccia
et
al
furthermor
vaccinia
viru
resist
interferon
blockad
inhibit
cell
transfect
protein
kinas
gene
meur
et
al
lee
esteban
intracellular
locat
synthetas
role
enzym
play
cellular
metabol
deserv
investig
cellfre
system
interferontr
cell
synthes
seri
oligo
compound
presenc
atp
dsrna
william
et
al
william
et
al
kerr
et
al
kerr
stark
oligo
characterist
phosphodiest
bond
instead
usual
bond
collect
refer
fig
synthes
minut
amount
normal
cell
interferontr
cell
viru
infect
laurenc
et
al
kerr
stark
synthes
higher
amount
extract
use
purifi
synthetas
even
chemic
haugh
et
al
kerr
stark
exact
role
play
antivir
action
interferon
remain
obscur
correl
antivir
action
interferon
presenc
synthetas
cultur
cell
jacobsen
et
al
lewi
taylor
grossberg
apart
role
oligo
could
play
action
interferon
anim
virus
direct
addit
cell
medium
prevent
viru
infect
alarcrn
et
al
activ
sever
anim
virus
includ
emc
viru
polioviru
concentr
mm
compound
inhibit
translat
rather
block
earli
step
infect
vsv
mode
action
picornavirus
remain
undetermin
et
al
sinc
charg
molecul
enter
easili
cell
core
number
deriv
use
inhibit
translat
block
viru
infect
intact
cell
imai
et
al
eppstein
et
al
haugh
et
al
sawai
et
al
goswami
et
al
eppstein
et
al
xyloadenosin
analogu
dephosphoryl
yterminu
much
stabl
activ
core
phosphorothio
analogu
interfer
activ
rnase
l
hela
cell
perhap
competit
authent
charachon
et
al
cordycepin
analogu
also
synthes
howev
although
analogu
antivir
effect
sever
dnacontain
virus
cultur
cell
precis
mode
action
picornavirus
known
doublestrand
polynucleotid
complex
mediat
interferon
induct
therebi
exert
antivir
effect
shugar
sehgal
et
al
shannon
streissl
et
al
apart
action
polynucleotid
may
antivir
activ
shugar
shannon
steb
streissl
et
al
thu
protect
mice
emc
viru
observ
poli
trna
poli
c
steb
et
al
steb
et
al
howev
antivir
action
polynucleotid
seem
mediat
interferon
induct
subsequ
stimul
immun
system
protect
also
achiev
immunosuppress
mice
athym
mice
steb
et
al
approach
use
block
viru
infect
involv
antisens
rna
ribozym
jame
antisens
oligonucleotid
oligonucleotid
deriv
possess
good
activ
varieti
anim
virus
stephenson
zamecnik
goodchild
et
al
leonetti
et
al
particularli
effect
poli
llysin
conjug
degol
et
al
phosphorothio
oligodeoxynucleotid
readili
enter
cell
stabl
leiter
et
al
agraw
et
al
phosphorodithio
dna
oligom
power
inhibitor
revers
transcriptas
marshal
caruth
knowledg
approach
use
block
picornavirus
synthesi
nucleosid
analogu
larg
direct
toward
inhibit
member
herpesvirida
famili
led
develop
effect
antivir
agent
acycloguanosin
schaeffer
et
al
elion
research
nucleosid
analogu
last
decad
concentr
find
select
inhibitor
hiv
nucleotid
analogu
possess
broad
spectrum
action
also
block
member
pieornavirida
famili
howev
gener
rule
certain
analogu
dhpa
aristeromycin
effect
polioviru
de
clercq
et
al
although
nucleosid
analogu
may
singl
viral
enzym
site
action
may
affect
varieti
cellular
viral
enzym
carrasco
vhzquez
particularli
true
adenosin
atp
guanosin
gtp
analogu
sinc
nucleosid
nucleotid
particip
varieti
function
therefor
anticip
action
nucleosid
analogu
rather
complex
carrasco
vzquez
knowledg
mode
action
none
nucleosid
analogu
activ
picornavirus
analyz
detail
although
ribavirin
l
show
interest
activ
pyrazofurin
flodbofuranosyl
fig
origin
call
pyrazomycin
isol
ferment
broth
streptomyc
candidu
antibiot
display
widespectrum
antivir
activ
good
antivir
index
activ
rhinoviru
respect
potent
ribavirin
excess
uridin
cultur
medium
abolish
antivir
effect
suggest
drug
block
step
metabol
nucleotid
gerzon
et
al
antagonist
uridin
metabol
block
orotidyl
deearboxylas
shugar
gutowski
et
al
also
inhibit
monophosph
aicar
formyltransferas
enzym
involv
purin
nucleotid
biosynthesi
inhibit
impdehydrogenas
activ
relat
compound
ribavirin
also
report
streeter
et
al
robin
et
al
yamada
et
al
ribavirin
fig
chemic
synthes
prove
also
widespectrum
antivir
agent
witkowski
et
al
streeter
et
al
hahn
show
activ
hiv
compound
good
antivir
activ
sever
anim
model
human
hahn
hayden
fernandez
et
al
patterson
fernandez
larsson
licens
usa
treatment
respiratori
syncyti
viru
infect
ribavirin
show
antivir
activ
concentr
well
caus
cytotox
hahn
sidwel
et
al
smith
kirkpatrick
although
mode
action
interest
antivir
agent
remain
obscur
idea
ribavirin
deplet
gtp
pool
andor
interfer
cap
mrna
format
goswami
et
al
support
sever
line
evid
smith
kirkpatrick
patterson
fernandez
larsson
picornavirus
possess
cap
structur
mrna
ribavirin
potent
inhibit
growth
inde
ribavirin
activ
sever
member
picornavirida
famili
includ
polioviru
de
clercq
van
aerschot
et
al
andersen
et
al
emc
viru
fmdv
de
la
torr
et
al
rhinovirus
coxsacki
viru
smith
kirkpatrick
andersen
et
al
ribavirin
antipicornaviru
agent
shown
cure
cell
persist
picornaviru
infect
de
la
torr
et
al
thu
bhk
cell
persist
infect
fmdv
cure
passag
medium
contain
low
concentr
ribavirin
de
la
torr
et
al
inhibit
fmdv
ribavirin
lytic
infect
requir
higher
dose
antivir
agent
de
la
torr
et
al
recent
action
ribavirin
selenazofurin
sever
picornavirus
investig
andersen
et
al
prevent
polioviru
protein
synthesi
ribavirin
occur
sever
round
viru
replic
take
place
andersen
et
al
drug
inhibit
polioviru
protein
synthesi
singl
growth
cycl
even
present
begin
infect
almela
carrasco
unpublish
observ
compound
structur
relat
ribavirin
selenazofurin
also
broad
spectrum
antivir
activ
tiazofurin
mainli
activ
rna
virus
srivastava
et
al
huggin
et
al
kirsi
et
al
bredinin
antibiot
isol
eupenicillium
brefeldianum
possess
broadspectrum
antivir
activ
three
antibiot
fig
pyrrolopyrimidin
nucleosid
adenosin
analogu
isol
differ
streptomyc
speci
tubercidin
streptomyc
tubercidiu
toyocamycin
streptomyc
toyocaensi
sangivamycin
streptomyc
rimosu
suhadolnik
three
potent
inhibitor
sever
rhinovirus
drug
concentr
gml
toxic
cell
concentr
higher
de
clercq
et
al
sever
tubercidin
analogu
synthes
much
potent
coxsackieviru
de
clercq
et
al
although
compound
may
therapeut
util
may
use
inhibitor
viral
rna
replic
particularli
picornavirus
cardiovirus
select
inhibitor
viral
rna
synthesi
describ
thu
far
know
compound
affect
emc
viru
know
exact
step
block
rhinoviru
coxsacki
viru
growth
neplanocin
fig
carbocycl
analogu
purin
nucleosid
ribos
moieti
replac
cyclopenten
ring
isol
actinomycet
ampullaria
regulari
neplanocin
well
carbocycl
analogu
adenosin
describ
potent
inhibitor
sadenosyllhomocystein
hydrolas
result
blockad
sadenosylmethioninedepend
methyl
reaction
neplanocin
b
c
also
broadspectrum
antivir
agent
show
activ
mainli
dna
rna
virus
de
clercq
agent
good
inhibitor
coxsacki
viru
vero
cell
concentr
neplanocin
inhibit
coxsacki
de
clercq
wherea
higher
concentr
agent
requir
block
polioviru
coxsacki
viru
hela
cell
de
clercq
rhinoviru
cell
de
clercq
et
al
carbocycl
analogu
adenosin
aristeromycin
cado
cctado
fig
also
activ
sever
anim
virus
de
clercq
cctado
activ
virus
hela
cell
carbocycl
cytidin
ccyd
cyclopentenylcytosin
cecyd
fig
broadspectrum
antivir
agent
activ
dnaand
rnacontain
anim
virus
polioviru
coxsacki
viru
rhinoviru
inhibit
ccyd
wherea
potent
block
cecyd
de
clercq
et
al
guanin
fig
base
analogu
guanin
good
antirhinoviru
activ
cell
drug
concentr
well
show
cytotox
sever
fluorin
nucleosid
synthes
evalu
antivir
potenc
van
aerschot
et
al
fig
activ
polioviru
coxsacki
viru
van
aerschot
et
al
although
action
deriv
may
relat
inhibit
sadenosyllhomocystein
hydrolas
exact
mode
action
remain
undetermin
cordycepin
ydeoxyadenosin
fig
first
natur
nucleosid
antibiot
isol
synthes
cordicep
militari
aspergillu
nidulan
inhibit
format
f
poli
tail
mrna
cordycepin
incorpor
terminu
sever
rna
act
chain
termin
antibiot
inhibit
replic
polioviru
rhinoviru
inhibit
latter
particularli
sensit
nair
panicali
triphosph
inhibit
incorpor
gmp
picornavirusspecif
polymeras
complex
cellfre
system
rna
product
synthes
vitro
lack
fulllength
viral
rna
indic
rna
chain
termin
occur
presenc
cordycepin
panicali
nair
amicetin
fig
antibiot
produc
streptomyc
fasciculatu
streptomyc
plicatu
inhibitor
peptid
bond
format
vhzquez
amicetin
activ
bacteria
less
effect
mammalian
cell
inhibit
polioviru
emc
viru
concentr
affect
cultur
cell
et
al
actinobolin
fig
anoth
translat
inhibitor
vquez
produc
streptomycesfasciculatu
also
effect
antivir
agent
cell
cultur
et
al
concentr
gml
drug
protect
hela
cell
infect
either
polioviru
emc
viru
carrasco
unpublish
result
tetracenomycin
c
fig
antibiot
produc
streptomyc
glaucescen
agent
block
growth
sever
anim
virus
includ
polioviru
emc
viru
et
al
concentr
gml
tetracenomycin
c
protect
hala
cell
monolay
infect
two
virus
et
al
sulfat
polysaccharid
oligosaccharid
inhibit
viral
replic
low
concentr
show
wide
spectrum
antivir
action
et
al
gonztlez
et
al
agent
advers
effect
cultur
cell
even
high
drug
concentr
et
al
gonzfilez
et
al
picornavirus
polioviru
affect
compound
wherea
emc
viru
growth
potent
block
carrageenan
lowmw
dextran
sulfat
gonzlez
et
al
preliminari
result
laboratori
indic
carrageenan
effect
protein
synthesi
emc
virusinfect
cell
implic
late
step
emc
viru
replic
target
agent
result
contrast
action
sulfat
polysaccharid
herp
viru
hiv
interfer
earli
step
infect
interact
viru
host
cell
receptor
gonzfilez
et
al
callahan
et
al
suramin
fig
polyanion
synthet
compound
inhibit
sever
viral
cellular
polyrneras
basu
modak
includ
revers
transcriptas
rna
tumour
virus
cellfre
system
de
clercq
jentsch
et
al
show
potent
antivir
effect
cultiv
cell
infect
differ
anim
virus
includ
emc
viru
polioviru
alarcbn
et
al
mitsuya
et
al
sola
et
al
schol
et
al
suramin
effect
emc
viru
protein
synthesi
even
present
earli
stage
infect
suggest
block
late
step
replic
cycl
carrasco
unpublish
result
trypan
blue
nonperm
dye
also
protect
cell
monolay
viral
infect
et
al
occur
charg
compound
balzarini
et
al
contrast
trypan
blue
high
concentr
suramin
advers
effect
either
cell
morpholog
cell
growth
even
prolong
incub
mice
infect
intravagin
surviv
treat
suramin
carrasco
unpublish
result
miner
condens
ion
ammonium
hpa
heteropolyanion
broad
spectrum
antivir
activ
block
emc
viru
werner
et
al
macham
et
al
singl
intraperiton
inject
hpa
protect
mice
emc
viru
werner
et
al
sinc
compound
polyanion
also
block
revers
transcriptas
chermann
et
al
ablashi
et
al
possibl
mode
action
may
similar
sulfat
polysaccharid
glycyrrhiz
acid
fig
natur
compound
extract
root
glycyrrhiza
glabra
compound
broad
spectrum
antivir
action
pompei
et
al
et
al
block
emc
viru
polioviru
growth
pompei
et
al
addit
agent
begin
emc
viru
infect
allow
synthesi
viral
protein
control
level
wherea
format
infecti
physic
particl
sever
diminish
lacal
carrasco
unpublish
observ
possibl
agent
block
assembl
new
emc
virion
action
yet
demonstr
antibiot
tenuazon
acid
fig
report
inhibitor
polioviru
growth
miller
et
al
later
found
compound
block
protein
synthesi
mammalian
cell
fact
first
inhibitor
eukaryot
ribosom
show
select
blockad
human
oppos
yeast
ribosom
carrasco
vquez
nphenylnarylthiourea
deriv
nphenylnarylthiourea
fig
inhibitor
coxsacki
viru
polioviru
fmdv
rhinovirus
drug
concentr
approxim
reduc
rhinoviru
growth
onelog
galabov
et
al
potenc
antivir
index
nphenylnarylthiourea
rather
low
probabl
compound
block
earli
step
rhinoviru
replic
adsorpt
galabov
et
al
galabov
activ
coxsacki
infect
mice
wherea
anoth
deriv
activ
fmdv
mice
guinea
pig
galabov
dichlorobenzo
fig
inhibit
sever
speci
rnacontain
virus
includ
echoviru
rhinoviru
effect
dna
virus
ohnishi
et
al
good
antivir
index
cultur
cell
effect
mice
influenza
viru
ohnishi
et
al
fig
belong
seri
deriv
block
dna
rna
virus
bonina
et
al
drug
concentr
gml
inhibit
polioviru
echoviru
coxsacki
viru
suggest
may
bind
structur
protein
prevent
virion
assembl
bonina
et
al
although
profound
studi
agent
requir
obtain
firm
conclus
mode
action
seri
watersolubl
thiazolinon
deriv
imto
fig
exhibit
antivir
properti
n
deriv
effect
influenza
coxsacki
virus
cultur
cell
harnden
et
al
variou
speci
genu
penicillium
produc
mycophenol
acid
fig
antibiot
block
replic
sever
anim
virus
includ
retrovirus
william
et
al
emc
viru
coxsacki
viru
cline
et
al
planteros
still
uncertain
blockad
due
simpli
cellular
toxic
new
class
depsipeptid
didemnin
fig
isol
caribbean
tunic
sea
squirt
famili
didemnida
effect
coxsacki
viru
rinehart
gloer
although
compound
particularli
didemnin
b
potent
antivir
effect
cell
cultur
cytotox
high
henc
antivir
index
poor
rinehart
gloer
atropin
atropin
fig
antivir
substanc
extract
atropa
belladonna
agent
inhibit
growth
sever
anim
virus
alarcrn
et
al
includ
polioviru
emc
viru
carrasco
unpublish
result
hydrochlorid
diqa
fig
relat
compound
dehydroemetin
papaverin
show
antivir
effect
picornavirus
princ
diqa
mgml
activ
coxsacki
viru
tissu
cultur
grunberg
princ
studi
mode
action
agent
indic
block
earli
step
columbia
sk
viru
growth
differ
adsorpt
viru
l
cell
murphi
glasgow
probabl
earli
step
entri
virion
cell
murphi
glasgow
clinic
trial
diqa
conduct
prevent
rhinoviru
infect
volunt
togo
et
al
oral
administr
prevent
develop
cold
symptom
treat
group
milder
placebotr
group
togo
et
al
rifamycin
ae
isol
broth
nocardia
mediterranei
rifampicin
chemic
deriv
rifamycin
b
fig
antibiot
sever
deriv
activ
sever
anim
virus
gurgo
et
al
fmdv
polioviru
growth
inhibit
rifampicin
suspens
cultur
cell
monolay
grado
ohlbaum
rifampicin
equal
effect
ad
viru
entri
specif
reproduc
inhibit
obscur
author
also
found
inhibit
virus
actinomycin
grado
ohlbaum
peptid
antibiot
isol
cultur
filtrat
metarhizium
anisoplia
exhibit
antivir
activ
polio
influenza
newcastl
diseas
viru
perhap
induc
antivir
substanc
relat
interferon
sakai
et
al
sever
undefin
agent
report
block
picornavirus
inde
antivir
research
well
acquaint
numer
list
public
claim
antivir
effect
extract
exud
secret
etc
divers
organ
mani
instanc
crude
prepar
even
purifi
compon
owe
antivir
activ
simpli
toxic
case
howev
specif
antivir
effect
document
thu
helenin
perhap
ribonucleoprotein
substanc
produc
penicillium
funiculosum
effect
columbia
sk
viru
sfv
shope
b
c
extract
differ
plant
fungi
interfer
growth
polioviru
coxsacki
viru
echovirus
cultur
cell
goulet
et
al
treatment
neurotoxoid
cobra
venom
interfer
polioviru
infect
monkey
cultur
cell
sander
et
al
sander
et
al
miller
et
al
abalon
halioti
refescen
marin
anim
commonli
use
food
china
juic
inhibitori
effect
mice
infect
polioviru
li
appl
juic
grape
juic
wine
virucid
virus
includ
polioviru
konowalchuk
speir
knowalchuk
speir
lipid
compon
milk
inhibit
viral
growth
sabin
fieldsteel
matthew
et
al
occur
acid
substanc
pine
cone
pine
seed
shell
extract
fukuchi
et
al
mukoyama
et
al
tea
extract
green
mukoyama
et
al
effect
perhap
relat
tannin
polyphenol
content
substanc
known
antivir
agent
green
kucera
herrmann
fukuchi
et
al
final
number
antivir
compound
report
neglig
effect
sever
picornavirus
compound
includ
camptothecin
horwitz
et
al
gossypol
dorsett
et
al
hypericin
tang
et
al
picornavirus
repres
one
best
understood
anim
viru
group
molecular
term
first
anim
virus
contain
rna
genom
sequenc
first
anim
viru
particl
solv
atom
resolut
first
anim
virus
total
synthes
test
tube
analysi
picornaviru
replic
cycl
mani
instanc
guid
work
viru
group
although
picornaviru
biolog
also
show
peculiar
typic
viru
group
eg
intern
initi
translat
picornaviru
mrna
picornaviru
inhibitor
much
aid
elucid
differ
step
picornaviru
replic
cycl
molecular
level
grow
armamentum
block
given
step
picornaviru
growth
provid
use
tool
investig
detail
molecular
biolog
picornavirus
addit
studi
provid
instanc
new
approach
develop
antivir
agent
case
recent
found
connect
picornaviru
genom
replic
membran
traffic
mammalian
cell
guinea
carrasco
irurzun
et
al
find
picornavirus
encod
viroporin
lama
carrasco
viral
protein
make
pore
membran
modifi
membran
permeabl
allow
passag
nonperm
inhibitor
virusinfect
cell
carrasco
fact
picornavirus
caus
diseas
human
anim
prompt
investig
effect
nontox
compound
inhibit
replic
eleg
studi
agent
bind
virion
particl
block
uncoat
exemplifi
one
refin
analys
mode
action
antivir
agent
also
provid
promis
compound
effect
attack
common
cold
human
rossmann
johnson
mckinlay
et
al
final
grow
interest
picornaviru
inhibitor
expand
number
new
antipicornaviru
agent
help
unravel
mode
action
mani
predict
futur
studi
broaden
knowledg
exact
mechan
action
inhibitor
provid
surpris
molecular
biolog
everinterest
group
virus
